Black Swan Sale

50% Off Elite

Days

Hours

Mins

Sec

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Open in Screener

ALIT

Alight Inc

Dec 01 • 11:11AM ET

2.40

+0.09 4.01 %

Technology • Software - Application • USA • NYSE

Peers: ADP PAYX WNS CNDT G FIS IT CSCO INTU VRSN

| Held by: VTI VB IWM VBR VXF AVUV IWN DFAT VTWO FNDA

Index	RUT	P/E	-	EPS (ttm)	-4.05	Insider Own	12.02%	Shs Outstand	522.64M	Perf Week	21.34%
Market Cap	1.28B	Forward P/E	4.09	EPS next Y	0.59	Insider Trans	0.31%	Shs Float	459.88M	Perf Month	-14.19%
Enterprise Value	2.98B	PEG	-	EPS next Q	0.24	Inst Own	94.85%	Short Float	5.17%	Perf Quarter	-38.87%
Income	-2.13B	P/S	0.56	EPS this Y	-3.87%	Inst Trans	-3.75%	Short Ratio	2.45	Perf Half Y	-54.84%
Sales	2.29B	P/B	0.63	EPS next Y	5.01%	ROA	-30.62%	Short Interest	23.79M	Perf YTD	-65.28%
Book/sh	3.83	P/C	2.97	EPS next 5Y	2.90%	ROE	-66.86%	52W High	8.05 -70.14%	Perf Year	-70.04%
Cash/sh	0.81	P/FCF	5.27	EPS past 3/5Y	-28.43% 23.41%	ROIC	-52.34%	52W Low	1.89 27.12%	Perf 3Y	-71.80%
Dividend Est.	-	EV/EBITDA	5.63	Sales past 3/5Y	-7.17% -3.85%	Gross Margin	21.71%	Volatility	6.51% 6.61%	Perf 5Y	-76.12%
Dividend TTM	0.16 (6.66%)	EV/Sales	1.30	EPS Y/Y TTM	-754.18%	Oper. Margin	5.42%	ATR (14)	0.14	Perf 10Y	-
Dividend Ex-Date	Dec 01, 2025	Quick Ratio	1.18	Sales Y/Y TTM	-12.37%	Profit Margin	-93.23%	RSI (14)	47.60	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	1.18	EPS Q/Q	-1367.27%	SMA20	5.21%	Beta	1.09	Target Price	5.33
Payout	-	Debt/Eq	1.07	Sales Q/Q	-3.96%	SMA50	-13.50%	Rel Volume	2.45	Prev Close	2.31
Employees	9500	LT Debt/Eq	1.04	Earnings	Nov 05 BMO	SMA200	-48.28%	Avg Volume	9.70M	Price	2.40
IPO	Jul 17, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6.83% -0.48%	Trades		Volume	7,044,204	Change	4.01%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-20-24	Downgrade	JP Morgan	Overweight → Neutral	$8
Jan-05-24	Resumed	Citigroup	Buy	$12
Dec-06-23	Initiated	Canaccord Genuity	Buy	$12
Nov-07-23	Initiated	UBS	Buy	$10
Jun-13-23	Initiated	Citigroup	Buy	$12
Dec-09-22	Initiated	Wedbush	Outperform	$13
Dec-06-22	Initiated	Needham	Buy	$12
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$15
Aug-02-22	Initiated	JP Morgan	Overweight	$10
Feb-08-22	Initiated	Stephens	Overweight	$15
Aug-16-21	Initiated	Credit Suisse	Outperform	$15
Jul-27-21	Resumed	DA Davidson	Buy	$20 → $16

Show Previous Ratings

Today 07:38AM	Meridian Growth Fund Reduced its Position in Alight (ALIT) in Q3 (Insider Monkey)
Nov-25-25 04:30PM	Alight to Present at UBS Global Technology and AI Conference (Business Wire) +5.16%
Nov-24-25 06:50PM	Alight, Applied Digital, Pure Storage, WEBTOON, and Xerox Stocks Trade Up, What You Need To Know (StockStory) +7.58%
Nov-18-25 12:50PM	Alight, OSI Systems, Kyndryl, Concentrix, and PAR Technology Stocks Trade Down, What You Need To Know (StockStory) -5.14%
08:02AM	Alight Earns Top 5 Rankings for User Experience and Vendor Satisfaction in 2025 Sapient HR Systems Report (Business Wire)
06:17AM	Loading…
06:17AM	Wall Street Bullish on Alight Inc. (ALIT) amid Disappointing Q3 Results (Insider Monkey)
Nov-17-25 10:32PM	Professional Staffing & HR Solutions Stocks Q3 Teardown: Alight (NYSE:ALIT) Vs The Rest (StockStory) -6.14%
01:45PM	UBS Maintains Buy Rating on Alight (ALIT), Lowers Price Target to $4 (Insider Monkey)
11:41AM	Why Alight (ALIT) Stock Is Trading Lower Today (StockStory)
Nov-12-25 12:32AM	The 5 Most Interesting Analyst Questions From Alight's Q3 Earnings Call (StockStory)
Nov-07-25 09:34PM	Alight (ALIT) and IBM Expand Partnership to Boost Employee Benefits with AI (Insider Monkey)
Nov-06-25 12:31AM	ALIT Q3 Deep Dive: Guidance Cut Amid Weak Project Pipeline and Margin Focus (StockStory)
Nov-05-25 04:02PM	Alight Inc (ALIT) Q3 2025 Earnings Call Highlights: Strong Cash Flow Amid Revenue Challenges (GuruFocus.com) -7.04%
08:45AM	Alight, Inc. (ALIT) Lags Q3 Earnings and Revenue Estimates (Zacks)
07:55AM	Alight (NYSE:ALIT) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
07:30AM	Loading…
07:30AM	Alight Reports Third Quarter 2025 Results (Business Wire)
07:25AM	Alight to Seek Stockholder Approval for Declassification (Business Wire)
Nov-04-25 07:58AM	Alight Inc (ALIT) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-03-25 10:04PM	What To Expect From Alight's (ALIT) Q3 Earnings (StockStory)
Oct-31-25 05:42AM	Needham Reaffirms Buy on Alight (ALIT) with $4.50 PT (Insider Monkey)
Oct-30-25 04:35PM	Alight Expands AI Collaboration With IBM to Advance Benefits Administration and Employee Experiences (Business Wire)
Oct-29-25 10:00AM	Alight, Inc. (ALIT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) -6.82%
09:00AM	Helping Workers Retire with Confidence: MetLife Expands Access to Lifetime Income Through Strategic Collaboration with Alight (Business Wire)
Oct-28-25 08:00AM	Alight introduces conversational GenAI tool to deliver personalized benefits guidance during annual enrollment (Business Wire)
12:03AM	3 Reasons to Sell ALIT and 1 Stock to Buy Instead (StockStory)
Oct-27-25 05:20PM	F5 Networks (FFIV) Q4 Earnings and Revenues Top Estimates (Zacks)
Oct-08-25 11:35AM	Why Alight (ALIT) Stock Is Trading Up Today (StockStory)
Oct-02-25 01:35AM	Alight Inc. (ALIT) Unveils Sword Health for Mental Health Needs (Insider Monkey)
Sep-30-25 05:00PM	Alight Inc. (ALIT) Adds Sword Health to its Alight Partner Network (Insider Monkey)
03:17PM	Needham Remains Bullish on Alight (ALIT), Partnerships Expansion Supports Company's Growth Outlook (Insider Monkey)
02:49PM	Loading…
02:49PM	Alight, Inc (ALIT) Adds Sword Health to Its Partner Network (Insider Monkey)
Sep-26-25 03:15PM	Alight, Iridium, CDW, First Advantage, and Xerox Shares Are Soaring, What You Need To Know (StockStory) +5.86%
Sep-19-25 02:49PM	Alight Inc. (ALIT) Focused on Diversifying and Strengthening Revenue Streams (Insider Monkey)
Sep-17-25 01:36PM	Why Alight (ALIT) Stock Is Up Today (StockStory)
08:00AM	Alight Expands Partner Network With the Addition of Sword Health (Business Wire)
Sep-16-25 08:00AM	Alight Study Finds Improvements in Wellbeing While Economic Anxieties Linger as Workers Seek More Guidance on Benefits (Business Wire)
Sep-11-25 01:15PM	Alight (ALIT) Charts New Course with AI and Strategic Partnerships (Insider Monkey) +5.31%
Sep-02-25 09:35AM	Here's Why Alight (ALIT) is Poised for a Turnaround After Losing 24.4% in 4 Weeks (Zacks)
Aug-28-25 04:05PM	Alight to Participate in the Citi 2025 Global TMT Conference (Business Wire)
Aug-27-25 05:57AM	Alight, Inc. (NYSE:ALIT) Gains Support as Expansion Efforts Take Shape (Insider Monkey)
Aug-23-25 03:58AM	Alight, Inc. (ALIT) Hits its 52-Week Low Amid Market Pressures (Insider Monkey)
Aug-22-25 11:45PM	Needham Reiterates a Buy Rating on Alight Inc (ALIT), Keeps the PT (Insider Monkey)
Aug-21-25 01:27PM	Needham Reduces PT on Alight, Inc. (ALIT); DA Davidson Maintains 'Buy' Rating (Insider Monkey)
Aug-20-25 12:13AM	DA Davidson Lowers the PT on Alight (ALIT), Keeps a Buy (Insider Monkey)
Aug-17-25 11:41PM	Alight Worklife Platform Receives AI-Powered Upgrade to Simplify Benefits, HR Management (Insider Monkey)
Aug-13-25 12:21AM	The 5 Most Interesting Analyst Questions From Alight's Q2 Earnings Call (StockStory)
Aug-12-25 11:53PM	ALIT Q2 Deep Dive: Guidance Lowered as Sales Cycles Lengthen and Execution Shifts (StockStory)
09:41AM	Alight (ALIT) Declares New Dividend After Returning $42 Million to Shareholders in Q2 (Insider Monkey)
Aug-11-25 04:35PM	Alight Earns 2025 Great Place To Work Certification for the Seventh Consecutive Year (Business Wire)
Aug-06-25 12:23PM	Alight Inc. (ALIT) Nosedives 18% as Earnings Disappoint (Insider Monkey)
Aug-05-25 08:48AM	Alight (NYSE:ALIT) Posts Better-Than-Expected Sales In Q2 But Full-Year Sales Guidance Misses Expectations (StockStory) -18.32%
08:45AM	Alight, Inc. (ALIT) Meets Q2 Earnings Estimates (Zacks)
07:30AM	Alight Reports Second Quarter 2025 Results (Business Wire)
Aug-04-25 05:20PM	ZoomInfo (GTM) Q2 Earnings and Revenues Beat Estimates (Zacks)
01:42PM	Upwork Set to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
09:33AM	Alight Inc (ALIT) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-03-25 11:05PM	Earnings To Watch: Alight (ALIT) Reports Q2 Results Tomorrow (StockStory)
Aug-01-25 12:44PM	ON Gears Up to Report Q2 Earnings: What's in the Cards for the Stock? (Zacks)
12:28PM	Coupang Set to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
12:23PM	FOXA Gears Up to Report Q4 Earnings: What's in Store for the Stock? (Zacks)
Jul-31-25 12:52PM	Snap Gears Up to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-30-25 10:00AM	Vertex (VERX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jul-29-25 10:00AM	Alight, Inc. (ALIT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-28-25 08:00AM	Alight Elevates Employer-employee Benefits Experience With Second Release of Alight Worklife for 2025 (Business Wire)
Jul-26-25 05:00PM	DA Davidson Maintains 'Buy' Rating on Alight, Inc. (ALIT), Sets PT at $10 (Insider Monkey)
Jul-24-25 12:06AM	3 Reasons to Sell ALIT and 1 Stock to Buy Instead (StockStory)
Jul-23-25 04:05PM	Alight Declares Quarterly Cash Dividend (Business Wire)
08:12AM	Does Alight (ALIT) Have Growth Opportunities? (Insider Monkey)
Jul-22-25 08:00AM	Alight to Announce Second Quarter 2025 Results (Business Wire)
Jul-17-25 02:46AM	Alight, Inc. (NYSE:ALIT) Insulates Itself From Short-term Market Swings (Insider Monkey)
Jul-15-25 02:12AM	Needham Reiterated a Buy Rating on Alight, Inc (ALIT) (Insider Monkey)
Jul-09-25 12:00PM	Alight (ALIT) Upgraded to Buy: Here's Why (Zacks)
Jun-30-25 06:04AM	Alight's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-29-25 11:32PM	Spotting Winners: Alight (NYSE:ALIT) And Professional Staffing & HR Solutions Stocks In Q1 (StockStory)
Jun-09-25 12:13PM	ALIT Q1 Earnings Call: Technology Initiatives and Contract Renewals Drive Steady Outlook (StockStory)
Jun-02-25 08:30AM	Alight Names Donna Dorsey as Chief Human Resources Officer (Business Wire)
May-29-25 09:36AM	Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought (MarketBeat)
May-14-25 08:00AM	Alight Appoints David Essary as Chief Strategy Officer (Business Wire)
May-13-25 08:31AM	Is Alight, Inc. (ALIT) the Best AI Stock to Buy Under $10? (Insider Monkey)
May-12-25 04:05PM	Alight to Participate in the J.P. Morgan Global Technology, Media and Communications Conference (Business Wire)
May-09-25 04:06AM	Alight, Inc. (ALIT): Among Billionaire Larry Robbins' Stock Picks with Huge Upside Potential (Insider Monkey)
03:21AM	Alight Inc (ALIT) Q1 2025 Earnings Call Highlights: Strong Revenue and Strategic Renewals Amid ... (GuruFocus.com)
May-08-25 11:29PM	Q1 2025 Alight Inc Earnings Call (Thomson Reuters StreetEvents) +7.27%
08:50AM	Alight, Inc. (ALIT) Lags Q1 Earnings Estimates (Zacks)
07:30AM	Alight Reports First Quarter 2025 Results (Business Wire)
May-07-25 09:58AM	Alight Inc (ALIT) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
May-02-25 12:36AM	3 of Wall Street's Favorite Stocks Walking a Fine Line (StockStory)
Apr-30-25 06:10PM	Udemy, Inc. (UDMY) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
04:15PM	Alight Declares Quarterly Cash Dividend (Business Wire)
11:02AM	Do Options Traders Know Something About Alight Stock We Don't? (Zacks)
Apr-29-25 09:07AM	3 Unprofitable Stocks with Questionable Fundamentals (StockStory)
Apr-24-25 08:00AM	Alight to Announce First Quarter 2025 Results (Business Wire)
Apr-23-25 12:23PM	Is Alight Inc. (NYSE:ALIT) the Best Cheap Stock to Buy Under $10? (Insider Monkey)
Apr-22-25 01:50AM	Is Alight, Inc. (ALIT) the Most Undervalued Penny Stock to Buy According to Hedge Funds? (Insider Monkey)
Apr-21-25 01:06PM	Alight Inc. (ALIT): Among Jeff Smith's Top Activist Targets (Insider Monkey)
Apr-18-25 10:28AM	Alight, Inc. (ALIT): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 (Insider Monkey)
Apr-16-25 08:00AM	Alight named to Newsweek's America's Greatest Workplaces for Mental Wellbeing 2025 (Business Wire)
Apr-08-25 10:04AM	Is Alight, Inc. (ALIT) the Best Low Cost Stock to Buy According to Billionaires? (Insider Monkey)
Apr-07-25 08:00AM	Alight Marks Onboarding of 200th Pension Risk Transfer Transaction (Business Wire)
Mar-31-25 12:07PM	Alight: Turning Around The Corner (Seeking Alpha)

Alight, Inc. engages in the provision of cloud-based integrated digital human capital and business solutions. The company was founded on June 01, 2017 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lopes Robert A. Jr.	Director	Nov 26 '25	Buy	2.39	10,000	23,899	80,168	Dec 01 08:01 AM
Massey Richard N	Director	Nov 26 '25	Buy	2.33	100,000	232,500	100,000	Dec 01 08:01 AM
SCHRIESHEIM ROBERT A	Director	Nov 26 '25	Buy	2.38	42,098	100,189	109,130	Dec 01 08:00 AM
Rajgopal Kausik	Director	Nov 25 '25	Buy	2.24	40,000	89,596	125,202	Nov 25 05:30 PM
Lopes Robert A. Jr.	Director	Aug 06 '25	Buy	4.40	3,000	13,200	63,951	Aug 08 10:22 AM
Lopes Robert A. Jr.	Director	Aug 07 '25	Buy	4.40	2,000	8,799	65,951	Aug 08 10:22 AM
SCHRIESHEIM ROBERT A	Director	Jun 16 '25	Buy	5.26	216	1,136	33,249	Jun 24 05:47 PM
Guilmette David D	Director	May 20 '25	Buy	5.69	50,000	284,645	600,750	May 20 06:02 PM
Lopes Robert A. Jr.	Director	Mar 13 '25	Buy	6.25	3,000	18,750	23,941	Mar 13 05:45 PM
Massey Richard N	Director	Mar 10 '25	Buy	6.39	100,000	639,420	1,573,489	Mar 11 07:57 PM
SCHRIESHEIM ROBERT A	Director	Mar 03 '25	Buy	6.79	22,092	150,000	22,092	Mar 04 05:51 PM
DNB Holdco, LLC	Affiliate	Dec 03 '24	Proposed Sale	7.90	12,000,000	94,800,000		Dec 03 08:07 PM

Open in Screener

NRDY

Nerdy Inc

Dec 01 • 11:11AM ET

1.33

-0.01 -0.75 %

Technology • Software - Application • USA • NYSE

Peers: COUR CHGG LRN PRDO THRY LOPE APEI EDU UTI ATAI

| Held by: IWM VTI VXF IWO VTWO IWC BYOB VTWG RSSL URTY

Index	RUT	P/E	-	EPS (ttm)	-0.34	Insider Own	67.57%	Shs Outstand	122.37M	Perf Week	29.12%
Market Cap	249.15M	Forward P/E	-	EPS next Y	-0.10	Insider Trans	0.59%	Shs Float	39.50M	Perf Month	31.68%
Enterprise Value	229.23M	PEG	-	EPS next Q	-0.04	Inst Own	16.95%	Short Float	17.35%	Perf Quarter	1.53%
Income	-40.83M	P/S	1.40	EPS this Y	2.17%	Inst Trans	-3.28%	Short Ratio	11.55	Perf Half Y	-20.36%
Sales	177.87M	P/B	6.71	EPS next Y	53.54%	ROA	-46.09%	Short Interest	6.85M	Perf YTD	-17.90%
Book/sh	0.20	P/C	7.62	EPS next 5Y	54.82%	ROE	-120.79%	52W High	2.18 -38.99%	Perf Year	-9.52%
Cash/sh	0.17	P/FCF	-	EPS past 3/5Y	-99.95% -317.67%	ROIC	-168.20%	52W Low	0.77 72.73%	Perf 3Y	-41.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.59% -	Gross Margin	61.52%	Volatility	11.01% 8.17%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.29	EPS Y/Y TTM	0.87%	Oper. Margin	-36.13%	ATR (14)	0.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.43	Sales Y/Y TTM	-9.86%	Profit Margin	-22.95%	RSI (14)	73.55	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.43	EPS Q/Q	28.06%	SMA20	33.39%	Beta	1.80	Target Price	1.79
Payout	-	Debt/Eq	0.00	Sales Q/Q	-1.36%	SMA50	19.58%	Rel Volume	2.06	Prev Close	1.34
Employees	600	LT Debt/Eq	0.00	Earnings	Nov 06 AMC	SMA200	-7.14%	Avg Volume	593.29K	Price	1.33
IPO	Nov 27, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.63% -4.54%	Trades		Volume	361,169	Change	-0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	JP Morgan	Neutral → Underweight
Nov-08-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Nov-08-24	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$6 → $1
Aug-09-24	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-09-24	Downgrade	Northland Capital	Outperform → Market Perform
Aug-09-24	Downgrade	JP Morgan	Overweight → Neutral
Aug-09-24	Downgrade	Canaccord Genuity	Buy → Hold	$5 → $3
Mar-11-24	Resumed	JP Morgan	Overweight	$5
Oct-09-23	Resumed	Barclays	Equal Weight	$5
Aug-28-23	Resumed	Raymond James	Outperform	$5.50
May-17-22	Downgrade	Goldman	Buy → Neutral	$8 → $3
Mar-30-22	Initiated	Cantor Fitzgerald	Overweight	$7
Mar-01-22	Reiterated	Needham	Buy	$13 → $8
Jan-07-22	Initiated	Goldman	Buy	$8
Nov-12-21	Initiated	JP Morgan	Overweight	$12
Oct-18-21	Initiated	Raymond James	Outperform	$13
Oct-18-21	Initiated	Needham	Buy	$13
Oct-18-21	Initiated	Barclays	Equal Weight	$9
Oct-15-21	Initiated	JMP Securities	Mkt Outperform	$13
Oct-04-21	Initiated	Canaccord Genuity	Buy	$14

Show Previous Ratings

Nov-13-25 01:38PM	Cantor Lowers Nerdy Price Target to $1.00, Maintains Neutral (Insider Monkey)
12:00PM	Nerdy (NRDY) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-07-25 12:14AM	Nerdy Inc (NRDY) Q3 2025 Earnings Call Highlights: AI-Driven Innovations and Strategic ... (GuruFocus.com) -7.97%
Nov-06-25 05:50PM	Nerdy Inc. (NRDY) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Nerdy Announces Third Quarter 2025 Financial Results (Business Wire)
08:00AM	Loading…
Nov-05-25 08:00AM	Nerdy Inc (NRDY) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-30-25 04:10PM	Nerdy to Announce Third Quarter 2025 Results on November 6, 2025 (Business Wire)
Oct-01-25 07:00AM	Varsity Tutors Introduces New Live+AI Tools and Capabilities That Teachers and School Administrators Can Use to Support Student Learning (Business Wire)
Sep-27-25 06:45AM	10 Hidden-Gem AI Stocks to Buy Right Now (Motley Fool)
Aug-26-25 06:46PM	Nerdy Appoints John Paszterko as Chief Operating Officer (Business Wire)
Aug-08-25 03:44AM	Nerdy Inc (NRDY) Q2 2025 Earnings Call Highlights: A Return to Growth and AI Innovations Propel ... (GuruFocus.com) -14.67%
Aug-07-25 05:25PM	Nerdy Inc. (NRDY) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +7.14%
04:01PM	Nerdy Announces Second Quarter 2025 Financial Results (Business Wire)
Aug-06-25 05:55PM	Grand Canyon Education (LOPE) Q2 Earnings and Revenues Top Estimates (Zacks)
Jul-17-25 04:01PM	Nerdy to Announce Second Quarter 2025 Results on August 7, 2025 (Business Wire)
01:00PM	Loading…
Jun-30-25 01:00PM	Varsity Tutors Signs White House Pledge to Advance AI Education for Americas Youth (Business Wire)
May-23-25 12:00PM	All You Need to Know About Nerdy (NRDY) Rating Upgrade to Buy (Zacks)
May-09-25 03:52AM	Nerdy Inc (NRDY) Q1 2025 Earnings Call Highlights: Surpassing Revenue Expectations Amidst ... (GuruFocus.com) -6.13%
May-08-25 05:15PM	Nerdy Inc. (NRDY) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Nerdy Announces First Quarter 2025 Financial Results (Business Wire)
May-07-25 11:19AM	Earnings To Watch: Nerdy Inc (NRDY) Reports Q1 2025 Results (GuruFocus.com)
Apr-29-25 05:26PM	Varsity Tutors Launches Live + AI Platform for Schools, Delivering Next-Generation Tutoring & Teacher Support System (Business Wire)
Apr-25-25 09:40AM	Are Consumer Discretionary Stocks Lagging Nerdy (NRDY) This Year? (Zacks)
Apr-24-25 04:01PM	Nerdy to Announce First Quarter 2025 Results on May 8, 2025 (Business Wire)
Mar-26-25 11:24AM	Is Nerdy Inc. (NYSE:NRDY) the Most Popular AI Penny Stock to Buy Under $5? (InsiderMonkey)
Mar-25-25 09:40AM	Is Nerdy (NRDY) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
Feb-27-25 04:01PM	Nerdy Announces Fourth Quarter 2024 Financial Results (Business Wire)
Feb-06-25 04:01PM	Nerdy to Announce Fourth Quarter and Full Year 2024 Results on February 27, 2025 (Business Wire)
Jan-30-25 07:00AM	Preble Shawnee Local School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Jan-27-25 07:00AM	Buckeye Valley Local School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
07:00AM	Loading…
Jan-15-25 07:00AM	Prodos Academy of Education and Sport Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +7.69%
Jan-06-25 07:00AM	Winton Woods City School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +19.02%
Dec-18-24 07:00AM	Manassas City Public Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -7.57%
Dec-17-24 07:00AM	Clover School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Dec-16-24 07:00AM	Iron County School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +9.20%
Dec-12-24 07:00AM	Parma City Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Dec-10-24 07:00AM	Indian Hill Exempted Village School District Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Dec-03-24 09:00AM	Nerdy Regains Compliance with NYSE Continued Listing Standard (Business Wire)
07:00AM	Oak Hills Local School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Nov-12-24 05:36PM	Nerdy Announces Receipt of Notice From NYSE (Business Wire) -8.97%
Nov-07-24 04:01PM	Nerdy Announces Third Quarter 2024 Financial Results (Business Wire) -7.28%
Nov-04-24 07:00AM	Forest Charter School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +6.84%
Oct-24-24 04:01PM	Nerdy to Announce Third Quarter 2024 Results on November 7, 2024 (Business Wire)
Oct-23-24 07:00AM	Harbor Science and Arts Charter School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -5.93%
Oct-21-24 07:00AM	Northpoint Charter School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Oct-10-24 07:00AM	McAlester Public Schools Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Oct-08-24 07:00AM	Harding Charter Preparatory School District Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Oct-04-24 07:00AM	Digital Ready Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for Students (Business Wire)
Sep-30-24 07:00AM	Mid-America Technology Center Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-17-24 07:00AM	North Hills School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-11-24 07:00AM	The Woodbury Leadership Academy Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-09-24 07:00AM	Velma-Alma School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-05-24 07:00AM	Estancia Valley Classical Academy Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-03-24 07:00AM	The NET Charter High School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -9.16%
Aug-28-24 07:00AM	St. Mary's School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -5.61%
Aug-26-24 07:00AM	Wapakoneta City Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Aug-21-24 07:00AM	The Township of Union Public Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Aug-19-24 07:00AM	Johnson County Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +13.09%
Aug-15-24 08:41PM	Nerdy, Inc. (NRDY) Analysis: Evaluating Growth and Investment Potential Among Top Technology Penny Stocks (Insider Monkey) +8.51%
Aug-08-24 04:01PM	Nerdy Announces Second Quarter 2024 Financial Results (Business Wire) +8.16% -48.06%
Aug-07-24 07:00AM	Frontier Schools Announce Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -6.96%
Jul-30-24 07:00AM	West Ada School District Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Jul-25-24 04:01PM	Nerdy to Announce Second Quarter 2024 Results on August 8, 2024 (Business Wire)
Jul-16-24 11:32AM	Nerdy (NRDY) Partners With Clarendon County School District (Zacks) +7.06%
07:30AM	3 Hidden AI Stocks That Could Outperform Nvidia (InvestorPlace)
Jul-15-24 10:00AM	3 Ultra-Speculative Stocks for Thrill-Seeking Traders (InvestorPlace)
07:00AM	Clarendon County School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
Jul-11-24 07:00AM	Ulysses USD 214 Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire) +9.68%
Jul-09-24 07:00AM	Hamtramck Public Schools Announce Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
Jul-04-24 01:07PM	3 Small-Cap Stocks Insiders Are Buying Hand Over Fist (InvestorPlace)
Jun-25-24 11:41PM	Nerdy Inc. (NRDY): Do Analysts See This AI Stock As a Promising Investment? (Insider Monkey)
Jun-11-24 06:30AM	3 Penny Stocks With the Power to 10X Your $1k Investment: June Edition (InvestorPlace) +10.76%
Jun-06-24 07:00AM	Western Michigan Christian High School and Middle School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
Jun-01-24 04:11PM	11 Best AI Penny Stocks to Invest in Now (Insider Monkey)
May-30-24 12:28PM	Nerdy's (NRDY) Online Tuitions Open for Trinity Lutheran School (Zacks)
May-29-24 07:00AM	Trinity Lutheran School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
May-17-24 07:52AM	3 Explosive Penny Stocks to Buy for 10X Returns in 2 Years (InvestorPlace)
May-10-24 07:00AM	Grayville Community School District 1 Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire) -8.19%
May-09-24 04:05PM	Nerdy to Participate in J.P. Morgan Conference (Business Wire)
May-08-24 07:00AM	Gateway Regional School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire) -8.68%
04:20AM	Nerdy Inc (NRDY) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Expansions (GuruFocus.com)
May-07-24 10:55PM	NRDY Stock Earnings: Nerdy Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:01PM	Nerdy Announces First Quarter 2024 Financial Results (Business Wire)
May-06-24 07:00AM	Birdville Independent School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
May-03-24 07:00AM	Eagle Mountain-Saginaw Independent School District Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources (Business Wire)
May-02-24 04:01PM	Nerdy to Participate in Needham Conference (Business Wire)
07:00AM	Franklin County School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
May-01-24 06:01AM	3 Stocks Poised to Profit from the Rise of Artificial Intelligence (InvestorPlace)
Apr-30-24 07:00AM	Cleveland School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
Apr-23-24 04:01PM	Nerdy to Announce First Quarter 2024 Results on May 7, 2024 (Business Wire)
Apr-19-24 07:00AM	Gateway Science Academy Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources (Business Wire)
Apr-16-24 07:00AM	Dent-Phelps R-III School District Selects Varsity Tutors for Schools to Provide Students With Additional Learning Resources (Business Wire)
Apr-15-24 11:41AM	Nerdy's (NRDY) Varsity Tutors for Schools Collabs with Prague HS (Zacks)
Apr-12-24 07:00AM	Prague High School Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources (Business Wire)
Apr-11-24 07:00AM	Fredonia-Moccasin Unified School District #6 Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources (Business Wire)
Apr-10-24 07:00AM	Marengo County School District Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources (Business Wire)
Apr-09-24 07:00AM	A+ Charter Schools, Inc. Selects Varsity Tutors for Schools to Provide Students With Additional Learning Resources (Business Wire)
Apr-08-24 09:36AM	Nerdy (NRDY) Partners With Rossville for Varsity Tutors Access (Zacks)
Apr-05-24 04:09PM	11 Best Technology Penny Stocks To Invest In Now (Insider Monkey)
07:00AM	Rossville Consolidated School District Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources (Business Wire)

Nerdy, Inc. engages in the business of operating a platform for live online learning. The firm is also involved in providing a purpose-built proprietary platform that leverages technology including artificial intelligence, to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals delivering superior value on both sides of the network. The company was founded by Charles K. Cohn in October 2007 and is headquartered in St. Louis, MO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cohn Charles K.	Chief Executive Officer	Nov 26 '25	Buy	1.25	144,783	180,979	1,540,307	Dec 01 07:12 AM
Cohn Charles K.	Chief Executive Officer	Nov 25 '25	Buy	1.16	119,242	138,321	1,395,524	Nov 28 08:58 AM
Cohn Charles K.	Chief Executive Officer	Nov 24 '25	Buy	1.05	238,749	250,686	1,276,282	Nov 26 09:25 AM
Cohn Charles K.	Chief Executive Officer	Nov 21 '25	Buy	1.06	257,210	273,343	31,053,279	Nov 25 08:48 AM
Cohn Charles K.	Chief Executive Officer	Nov 19 '25	Buy	0.91	270,578	246,226	30,779,769	Nov 21 08:13 AM
Pello Jason H.	Chief Financial Officer	Nov 17 '25	Sale	0.84	43,969	36,934	1,803,055	Nov 18 08:12 PM
Swenson Christopher C.	Chief Legal Officer	Nov 17 '25	Sale	0.84	28,810	24,200	1,509,587	Nov 18 08:11 PM
Mrva Gregory	Director	Nov 13 '25	Sale	0.89	25,000	22,250	710,991	Nov 14 04:03 PM
Mrva Gregory	Director	Nov 14 '25	Sale	0.85	25,000	21,250	685,991	Nov 14 04:03 PM
Mrva Gregory	Director	Nov 13 '25	Proposed Sale	0.87	50,000	43,500		Nov 13 04:44 PM
Swenson Christopher C.	Chief Legal Officer	Sep 16 '25	Sale	1.27	18,428	23,404	1,538,397	Sep 18 05:44 PM
Pello Jason H.	Chief Financial Officer	Sep 16 '25	Sale	1.27	30,714	39,007	1,847,024	Sep 18 05:43 PM
Blunt Abigail	Director	Aug 29 '25	Buy	1.36	25,000	34,000	226,000	Sep 03 09:00 AM
Swenson Christopher C.	Chief Legal Officer	Aug 18 '25	Sale	1.27	37,845	48,063	1,556,825	Aug 20 05:43 PM
Pello Jason H.	Chief Financial Officer	Aug 18 '25	Sale	1.27	52,866	67,140	1,877,738	Aug 20 05:42 PM
Pello Jason H.	Chief Financial Officer	Jun 16 '25	Sale	1.61	29,530	47,543	1,930,604	Jun 18 04:43 PM
Swenson Christopher C.	Chief Legal Officer	Jun 16 '25	Sale	1.61	17,718	28,526	1,594,670	Jun 18 04:43 PM
Blunt Abigail	Director	May 23 '25	Buy	1.60	7,370	11,792	196,000	May 28 04:52 PM
Blunt Abigail	Director	May 27 '25	Buy	1.62	5,000	8,100	201,000	May 28 04:52 PM
Pello Jason H.	Chief Financial Officer	May 16 '25	Sale	1.67	76,794	128,246	1,960,134	May 20 05:43 PM
Swenson Christopher C.	Chief Legal Officer	May 16 '25	Sale	1.67	53,514	89,368	1,612,388	May 20 05:42 PM
Pello Jason H.	Chief Financial Officer	Mar 17 '25	Sale	1.54	31,877	49,091	2,036,928	Mar 19 06:47 PM
Swenson Christopher C.	Chief Legal Officer	Mar 17 '25	Sale	1.54	19,126	29,454	1,665,902	Mar 19 06:46 PM
Pello Jason H.	Chief Financial Officer	Mar 12 '25	Sale	1.51	75,000	113,250	2,068,805	Mar 14 05:02 PM
Blunt Abigail	Director	Mar 10 '25	Buy	1.51	14,530	21,940	188,630	Mar 12 04:37 PM
Pello Jason H.	Officer	Mar 12 '25	Proposed Sale	1.53	75,000	114,810		Mar 12 10:14 AM
Pello Jason H.	Chief Financial Officer	Feb 18 '25	Sale	1.80	81,381	146,486	2,143,805	Feb 20 06:08 PM
Swenson Christopher C.	Chief Legal Officer	Feb 18 '25	Sale	1.80	58,220	104,796	1,685,028	Feb 20 06:07 PM
Pello Jason H.	Chief Financial Officer	Dec 16 '24	Sale	1.84	30,242	55,645	2,225,186	Dec 18 05:55 PM
Cohn Charles K.	Chief Executive Officer	Dec 13 '24	Buy	1.70	3,000,000	5,100,000	28,509,191	Dec 17 08:59 AM
Cohn Charles K.	Chief Executive Officer	Dec 16 '24	Buy	1.99	2,000,000	3,980,000	30,509,191	Dec 17 08:59 AM
Swenson Christopher C.	Chief Legal Officer	Dec 13 '24	Sale	1.49	25,000	37,250	1,743,248	Dec 16 05:55 PM
Cohn Charles K.	Chief Executive Officer	Dec 12 '24	Buy	1.61	300,000	483,000	850,333	Dec 16 05:54 PM
CHRISTOPHER C SWENSON	Officer	Dec 13 '24	Proposed Sale	1.49	25,000	37,298		Dec 13 04:36 PM
Cohn Charles K.	Chief Executive Officer	Dec 09 '24	Buy	1.78	300,000	534,000	700,333	Dec 11 05:45 PM
Cohn Charles K.	Chief Executive Officer	Dec 06 '24	Buy	1.58	168,361	266,010	13,194,231	Dec 10 05:25 PM
Cohn Charles K.	Chief Executive Officer	Dec 05 '24	Buy	1.54	426,758	657,207	25,509,191	Dec 09 05:03 PM
Blunt Abigail	Director	Dec 05 '24	Buy	1.47	33,055	48,591	174,100	Dec 09 05:02 PM

Open in Screener

OBDC

Blue Owl Capital Corp

Dec 01 • 11:11AM ET

13.24

+0.07 0.57 %

Financial • Asset Management • USA • NYSE

OBDC Blue Owl Capital Corp daily Stock Chart

Peers: ARCC MAIN GBDC TCPC CSWC HTGC SLRC PSEC PNNT TPVG

| Held by: BIZD PBDC PSP FBDC HYIN COPY FXED GINN GABF PCR

Index	-	P/E	9.41	EPS (ttm)	1.41	Insider Own	0.93%	Shs Outstand	511.05M	Perf Week	7.33%
Market Cap	6.77B	Forward P/E	9.35	EPS next Y	1.42	Insider Trans	3.25%	Shs Float	506.28M	Perf Month	3.40%
Enterprise Value	15.98B	PEG	-	EPS next Q	0.36	Inst Own	51.74%	Short Float	1.95%	Perf Quarter	-6.92%
Income	663.21M	P/S	4.13	EPS this Y	-18.90%	Inst Trans	-	Short Ratio	1.84	Perf Half Y	-8.08%
Sales	1.64B	P/B	0.89	EPS next Y	-8.27%	ROA	4.18%	Short Interest	9.87M	Perf YTD	-11.93%
Book/sh	14.89	P/C	21.07	EPS next 5Y	-9.71%	ROE	9.77%	52W High	15.65 -15.34%	Perf Year	-11.69%
Cash/sh	0.63	P/FCF	9.07	EPS past 3/5Y	-1.44% -0.11%	ROIC	3.87%	52W Low	11.65 13.74%	Perf 3Y	5.30%
Dividend Est.	1.51 (11.39%)	EV/EBITDA	12.87	Sales past 3/5Y	15.70% 15.95%	Gross Margin	75.57%	Volatility	2.35% 2.37%	Perf 5Y	1.68%
Dividend TTM	1.48 (11.14%)	EV/Sales	9.74	EPS Y/Y TTM	-12.79%	Oper. Margin	75.73%	ATR (14)	0.29	Perf 10Y	-
Dividend Ex-Date	Dec 31, 2025	Quick Ratio	1.44	Sales Y/Y TTM	5.55%	Profit Margin	40.45%	RSI (14)	66.19	Recom	1.38
Dividend Gr. 3/5Y	6.08% 5.73%	Current Ratio	1.44	EPS Q/Q	-27.70%	SMA20	6.77%	Beta	0.68	Target Price	14.58
Payout	97.03%	Debt/Eq	1.25	Sales Q/Q	28.83%	SMA50	4.39%	Rel Volume	0.68	Prev Close	13.17
Employees	-	LT Debt/Eq	1.25	Earnings	Nov 05 AMC	SMA200	-5.25%	Avg Volume	5.38M	Price	13.24
IPO	Jul 18, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6.68% -2.97%	Trades		Volume	1,077,750	Change	0.57%

Date	Action	Analyst	Rating Change	Price Target Change
May-13-25	Resumed	B. Riley Securities	Buy	$15
Apr-11-25	Initiated	Jefferies	Buy	$16
Mar-17-25	Upgrade	Wells Fargo	Underweight → Equal Weight	$14 → $15
Dec-12-24	Downgrade	Keefe Bruyette	Mkt Perform → Underperform	$15.50 → $14
Aug-09-24	Downgrade	Raymond James	Outperform → Mkt Perform
May-10-24	Reiterated	Hovde Group	Outperform	$16 → $17
Jan-08-24	Downgrade	B. Riley Securities	Buy → Neutral	$15.50
Jul-28-23	Initiated	B. Riley Securities	Buy	$15.25
Jul-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$13.75 → $12
May-06-22	Upgrade	Hovde Group	Market Perform → Outperform	$15
Mar-07-22	Initiated	Hovde Group	Market Perform
Apr-01-21	Initiated	Oppenheimer	Outperform	$15
Feb-26-21	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$13.50 → $15
Feb-24-21	Upgrade	Janney	Neutral → Buy	$15
Nov-06-20	Upgrade	Ladenburg Thalmann	Neutral → Buy	$13.50
Nov-05-20	Upgrade	Compass Point	Neutral → Buy
Oct-26-20	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$14
Jul-09-20	Initiated	JMP Securities	Mkt Outperform	$14.50
Apr-16-20	Upgrade	Raymond James	Mkt Perform → Outperform	$13.50
Apr-13-20	Upgrade	BofA/Merrill	Neutral → Buy	$15

Show Previous Ratings

Nov-28-25 07:25AM	Blue Owl Capital Inc. Stock Has Dropped To A Very Attractive 5.8% Yield (GuruFocus.com)
Nov-26-25 12:16PM	Blue Owl Is Having a Rough Year. Its Co-CEO Says Investors' Fears Are 'Ungrounded.' (Barrons.com)
Nov-21-25 04:51PM	Blue Owl scraps merger of two private credit funds. Here's why (Yahoo Finance Video)
Nov-20-25 09:18AM	Blue Owl Backs Off: Market Conditions Send the Merger Flying South (Zacks)
Nov-19-25 04:57PM	Blue Owl Calls Off Ill-Starred Fund Merger (Barrons.com)
03:09PM	Loading…
03:09PM	Blue Owl Scraps Merger of Private Credit Funds After Selloff (Bloomberg)
01:08PM	BLS isn't publishing Oct. jobs report, Kraken files for US IPO (Yahoo Finance Video)
12:40PM	Blue Owl Scraps Merger of Private Credit Funds (Bloomberg)
12:05PM	Blue Owl co-president on company's decision to terminate merger of private credit funds (CNBC TV)
09:27AM	Blue Owl Offered a Way Out to Private Credit Investors. Why It's a Tough Sell. (Barrons.com)
09:10AM	Blue Owl Capital Corporation and Blue Owl Capital Corporation II Announce Termination of Merger (PR Newswire)
Nov-18-25 04:32PM	Blue Owl Offered Liquidity to Private Credit Investors. Why It's a Tough Sell. (Barrons.com)
Nov-12-25 09:36AM	Blue Owl Capital price target lowered to $16 from $17 at Truist (TipRanks)
Nov-11-25 11:16AM	Blue Owl Capital Corp (OBDC) Maintains Outperform Rating Despite Price Target Cut (Insider Monkey)
10:25AM	Blue Owl Capital Declines 5.5% Since Q3 Earnings Miss on High Costs (Zacks)
04:22PM	Loading…
Nov-06-25 04:22PM	Blue Owl Capital Corp (OBDC) Q3 2025 Earnings Call Highlights: Strategic Merger and Solid ... (GuruFocus.com) -5.32%
Nov-05-25 07:30PM	Blue Owl Capital Corporation (OBDC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:15PM	Blue Owl Capital Corporation (OBDC) Q3 Earnings and Revenues Miss Estimates (Zacks)
04:37PM	Blue Owl Capital Corporation Announces September 30, 2025 Financial Results (PR Newswire)
04:35PM	Blue Owl Capital Corporation and Blue Owl Capital Corporation II Announce Merger Agreement (PR Newswire)
Oct-30-25 10:00AM	IREN Limited (IREN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-29-25 10:00AM	Analysts Estimate Blue Owl Capital Corporation (OBDC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-24-25 10:35AM	Private-Asset Star Blue Owl Has Been Flying High. Is It Too Close to the Sun? (Barrons.com)
Oct-15-25 12:58PM	Blue Owl Capital's Packer: First Brands & Tricolor collapses were idiosyncratic, not broader risk (CNBC TV)
Oct-02-25 10:25AM	Blue Owl Capital's Growth Story: Solid Portfolio, Shaky Efficiency? (Zacks)
Oct-01-25 08:30AM	Blue Owl Capital Corporation Schedules Earnings Release and Quarterly Earnings Call to Discuss its Third Quarter Ended September 30, 2025 Financial Results (PR Newswire)
Sep-16-25 05:03PM	Are BDCs Signaling a Bigger Rate Drop? Their Stocks Are Dropping as Rates Droop. (Barrons.com)
Sep-02-25 12:16PM	Viral U.S. Open moment raises brand awareness for alternative asset manager Blue Owl (CNBC TV)
Aug-27-25 09:59AM	Blue Owl Capital Corporation (OBDC): A Bull Case Theory (Insider Monkey)
Aug-11-25 02:12PM	Blue Owl Capital's Q2 Earnings Beat on Strong Investment Results (Zacks)
07:58PM	Loading…
Aug-08-25 07:58PM	Meta Just Landed $29 Billion for AI -- And Wall Street's Power Players Are Fighting to Join In (GuruFocus.com)
03:24AM	Blue Owl Capital Corp (OBDC) Q2 2025 Earnings Call Highlights: Strong ROE and Strategic Growth ... (GuruFocus.com)
Aug-06-25 08:30PM	Blue Owl Capital Corporation (OBDC) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
06:25PM	Blue Owl Capital Corporation (OBDC) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:15PM	Blue Owl Capital Corporation Announces June 30, 2025 Financial Results (PR Newswire)
Aug-05-25 09:27AM	Earnings To Watch: Blue Owl Capital Corp (OBDC) Reports Q2 2025 Result (GuruFocus.com)
09:15AM	Countdown to Blue Owl Capital Corporation (OBDC) Q2 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
Jul-22-25 03:41AM	Here's Why Ares Capital Stock Is a Buy Before July 29 (Motley Fool)
Jul-01-25 08:00AM	Blue Owl Capital Corporation Schedules Earnings Release and Quarterly Earnings Call to Discuss its Second Quarter Ended June 30, 2025 Financial Results (PR Newswire)
Jun-06-25 11:31AM	Blue Owl Capital Corporation (OBDC) Up 4.7% Since Last Earnings Report: Can It Continue? (Zacks)
May-14-25 02:33PM	Are Options Traders Betting on a Big Move in Blue Owl Capital (OBDC) Stock? (Zacks)
May-12-25 10:09AM	Blue Owl Capital's Q1 Earnings Miss Estimates on Higher Expenses (Zacks)
May-11-25 01:48PM	Seeking 10% Dividend Yield? Jefferies and BTIG Suggest 2 Dividend Stocks to Buy (TipRanks)
May-09-25 03:29AM	Blue Owl Capital Corp (OBDC) Q1 2025 Earnings Call Highlights: Navigating Economic Uncertainty ... (GuruFocus.com)
May-08-25 02:45AM	Blue Owl Capital Corporation: Fairly Valued, Ahead Of Q1 (Seeking Alpha)
May-07-25 09:00PM	Compared to Estimates, Blue Owl Capital Corporation (OBDC) Q1 Earnings: A Look at Key Metrics (Zacks)
07:05PM	Blue Owl Capital Corporation (OBDC) Q1 Earnings Miss Estimates (Zacks)
04:57PM	Blue Owl Capital declares $0.37 dividend (Seeking Alpha)
04:41PM	Blue Owl Capital Corp. Q1 earnings miss consensus; NAV falls (Seeking Alpha)
04:24PM	Blue Owl Capital Corporation Announces March 31, 2025 Financial Results (PR Newswire)
03:03PM	Blue Owl Capital Is Underappreciated, Here's Why (Seeking Alpha)
09:40AM	Blue Owl Capital Corp (OBDC) Q1 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
May-06-25 09:15AM	Exploring Analyst Estimates for Blue Owl Capital Corporation (OBDC) Q1 Earnings, Beyond Revenue and EPS (Zacks)
May-02-25 11:44PM	BDC Weekly Review: BDCs Are Taking Advantage Of Wider Spreads (Seeking Alpha)
12:28PM	Why We Have Been Buying BDCs In This Drawdown (Seeking Alpha)
11:14AM	Ares Capital: A Golden Opportunity (Seeking Alpha)
10:10AM	Blue Owl Capital to Report Q1 Earnings: What Do the Estimates Say? (Zacks)
10:00AM	TeraWulf Inc. (WULF) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-30-25 10:01AM	Analysts Estimate Blue Owl Capital Corporation (OBDC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-28-25 08:00AM	These Assets Helped Me Achieve $3000 In Monthly Dividend Income (Seeking Alpha)
Apr-27-25 09:15AM	BIZD: Panic Selloff Is A Golden Opportunity (Seeking Alpha)
Apr-25-25 02:47PM	I'm Buying 7-12% Yields For Recurring Income (Seeking Alpha)
Apr-24-25 09:03AM	Out Of 70 Graham Value All-Stars, These 16 'Safer' Stocks Stand Out For April (Seeking Alpha)
08:50AM	Where Will Ares Capital Corporation Be in 1 Year? (Motley Fool)
Apr-23-25 12:26PM	Fidus Investment: Irresistible Buying Opportunity (Seeking Alpha)
Apr-21-25 07:31PM	Focusing On Lower Risk Shares (And Updated Charts For High-Yield Stocks) (Seeking Alpha)
Apr-19-25 11:44AM	BDC Weekly Review: Consequences Of The Trade War For BDCs (Seeking Alpha)
Apr-17-25 08:10AM	My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys (Seeking Alpha)
04:17AM	New Income Opportunities And Stress-Testing Our 2025 Playbook (Seeking Alpha)
Apr-13-25 02:06PM	BDC Weekly Review: BDCs Plunge On Macro Fears (Seeking Alpha)
Apr-11-25 03:00PM	Undercovered Dozen: VICI Properties, General Dynamics, LandBridge, Anavex + (Seeking Alpha)
Apr-10-25 01:15PM	Vantage Mobility Appoints Daryl Adams as CEO (PR Newswire)
05:01AM	Oaktree Specialty Lending: Not The Best Investment Choice, Despite High Dividend Yield (Seeking Alpha)
Apr-07-25 07:00AM	OBDC: Sell-Off Makes Its Yield Soar To 13% (Seeking Alpha)
Apr-06-25 12:48PM	Blue Owl Capital: Optically Interesting, But Still Not Good Enough (Seeking Alpha)
10:00AM	The Market Is Crashing, But We Are Rejoicing (Seeking Alpha)
Apr-03-25 04:15PM	Blue Owl Capital Corporation Schedules Earnings Release and Quarterly Earnings Call to Discuss its First Quarter Ended March 31, 2025 Financial Results (PR Newswire) -7.64%
09:00AM	Skylight Fuels Family-First Innovation with $50 Million of Financing From SG Credit Partners and Wingspire Capital (PR Newswire)
Apr-01-25 11:00AM	2 Must-Own Dividends Up To 11% Yield (Seeking Alpha)
Mar-31-25 01:30PM	SLR Investment: 9.6% Yield And NAV Growth Make It A Buy (Seeking Alpha)
11:00AM	Retirement Income: I'm Seeking Treasure In These 7-9% Yields (Seeking Alpha)
Mar-26-25 03:08PM	Golub Capital BDC's NAV, Valuation And Dividend Vs. 11 BDC Peers - Part 2 (Includes Updated Dividend Projections) (SeekingAlpha)
11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
Mar-21-25 11:30AM	Why Is Blue Owl Capital Corporation (OBDC) Down 3% Since Last Earnings Report? (Zacks)
Mar-20-25 03:01PM	Opportunities In The Income Market Drawdown (SeekingAlpha)
09:40AM	My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys (SeekingAlpha)
01:31AM	Goldman Sachs BDC: Dividend Alignment, But Still A Buy (SeekingAlpha)
Mar-19-25 04:05PM	15% Yields Want To Mug Your Dividends (SeekingAlpha)
Mar-13-25 01:06PM	IonQ short, gold prices, SoFi-Blue Owl Capital: Market Minute (Yahoo Finance Video)
Feb-19-25 04:40PM	Blue Owl Capital Corporation Reports Full Year Results and Fourth Quarter Net Investment Income Per Share of $0.47 and Net Asset Value Per Share of $15.26 (PR Newswire)
Feb-12-25 10:00AM	Blue Owl Capital Corporation (OBDC) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jan-22-25 08:30AM	Blue Owl Capital Corporation Schedules Earnings Release and Quarterly Earnings Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2024 Financial Results (PR Newswire)
Jan-16-25 08:30AM	Blue Owl Capital Corporation Announces Preliminary Fourth Quarter Financial Results and Portfolio Update (PR Newswire)
Jan-13-25 08:33AM	Blue Owl Capital Corporation Completes Merger with Blue Owl Capital Corporation III (PR Newswire)
Jan-08-25 04:30PM	Blue Owl Capital Corporation and Blue Owl Capital Corporation III Announce Shareholder Approvals of Merger (PR Newswire)
Jan-03-25 09:39AM	Are Options Traders Betting on a Big Move in Blue Owl Capital Corporation (OBDC) Stock? (Zacks)
09:07AM	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend that Shareholders Vote 'FOR' the Pending Merger between OBDC and OBDE (PR Newswire)
Dec-16-24 04:42PM	Blue Owl Capital Corporation III Declares Special Dividend of $0.52 Per Share (PR Newswire)
Nov-14-24 08:38AM	Implied Volatility Surging for Blue Owl Capital (OBDC) Stock Options (Zacks)
Nov-06-24 04:37PM	Blue Owl Capital Corporation Reports Third Quarter Net Investment Income Per Share of $0.47 and Net Asset Value Per Share of $15.28 (PR Newswire)

Blue Owl Capital Corp seeks investment opportunities in middle market companies located in the United States with an EBITDA of USD 10 - 250 million and revenues of USD 50 - 2500 million . The fund focuses on broad range of sectors and industries. It provides financing in the form of senior secured,unsecured loans, subordinated loans, mezzanine loans & a lesser extent, equity-related securities & warrants for growth, acquisitions, market, product expansion, re-financings and recapitalizations with an investment size of USD 20 - 250 million. It also acts as a lead investor.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Reddy Neena	Vice President and Secretary	Nov 26 '25	Buy	13.06	7,890	103,065	7,890	Dec 01 06:08 AM
Nicholson Logan	President	Nov 18 '25	Buy	11.75	25,000	293,690	55,032	Nov 19 05:21 PM
Packer Craig	Chief Executive Officer	Nov 18 '25	Buy	11.75	83,200	977,924	41,600	Nov 19 05:03 PM
Temple Chris	Director	Nov 12 '25	Buy	12.03	8,000	96,240	59,000	Nov 14 04:15 PM
Weiler Melissa	Director	Nov 10 '25	Buy	11.99	10,000	119,900	49,734	Nov 12 04:15 PM
Nicholson Logan	President	Aug 15 '25	Buy	14.19	15,553	220,640	30,032	Aug 18 04:05 PM
Woolridge Victor	Director	May 27 '25	Buy	14.45	6,915	99,922	28,191	May 28 08:48 PM
Temple Chris	Director	Mar 06 '25	Buy	14.80	15,000	222,000	51,000	Mar 10 04:05 PM

Open in Screener

DGICA

Donegal Group Inc

Dec 01 • 11:11AM ET

20.18

+0.05 0.25 %

Financial • Insurance - Property & Casualty • USA • NASD

DGICA Donegal Group Inc daily Stock Chart

Peers: PGR TRV CINF ALL HIG SIGI AFG KMPR WRB THG

| Held by: VTI IWM SMDV AVUV VXF DFAT IWN FSMD DFSV DFAS

Index	RUT	P/E	8.32	EPS (ttm)	2.43	Insider Own	53.68%	Shs Outstand	31.03M	Perf Week	2.18%
Market Cap	717.87M	Forward P/E	10.17	EPS next Y	1.98	Insider Trans	1.95%	Shs Float	16.70M	Perf Month	9.79%
Enterprise Value	-	PEG	0.60	EPS next Q	0.44	Inst Own	36.31%	Short Float	2.68%	Perf Quarter	9.97%
Income	86.15M	P/S	0.73	EPS this Y	49.03%	Inst Trans	-	Short Ratio	3.39	Perf Half Y	-0.98%
Sales	988.19M	P/B	1.16	EPS next Y	-5.54%	ROA	4.83%	Short Interest	0.45M	Perf YTD	30.45%
Book/sh	17.40	P/C	-	EPS next 5Y	13.89%	ROE	15.10%	52W High	21.12 -4.45%	Perf Year	22.75%
Cash/sh	-	P/FCF	8.12	EPS past 3/5Y	22.75% -1.76%	ROIC	13.01%	52W Low	14.17 42.41%	Perf 3Y	33.11%
Dividend Est.	0.71 (3.53%)	EV/EBITDA	-	Sales past 3/5Y	6.62% 4.03%	Gross Margin	-	Volatility	3.05% 2.63%	Perf 5Y	41.91%
Dividend TTM	0.72 (3.56%)	EV/Sales	-	EPS Y/Y TTM	224.95%	Oper. Margin	10.89%	ATR (14)	0.48	Perf 10Y	45.81%
Dividend Ex-Date	Nov 03, 2025	Quick Ratio	-	Sales Y/Y TTM	0.93%	Profit Margin	8.72%	RSI (14)	60.00	Recom	2.33
Dividend Gr. 3/5Y	2.54% 3.53%	Current Ratio	0.48	EPS Q/Q	8.77%	SMA20	2.72%	Beta	0.02	Target Price	21.00
Payout	45.13%	Debt/Eq	0.06	Sales Q/Q	-2.31%	SMA50	4.17%	Rel Volume	0.68	Prev Close	20.13
Employees	851	LT Debt/Eq	0.06	Earnings	Oct 30 BMO	SMA200	7.57%	Avg Volume	131.89K	Price	20.18
IPO	Apr 24, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.46% -5.57%	Trades		Volume	26,692	Change	0.25%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-02-25	Upgrade	Janney	Neutral → Buy
Dec-20-23	Initiated	Janney	Neutral	$15
Nov-16-21	Downgrade	Keefe Bruyette	Outperform → Mkt Perform
Nov-01-17	Upgrade	Keefe Bruyette	Mkt Perform → Outperform
Oct-31-17	Upgrade	Boenning & Scattergood	Neutral → Outperform
May-25-17	Initiated	Boenning & Scattergood	Neutral
Dec-20-16	Downgrade	Keefe Bruyette	Outperform → Mkt Perform

Nov-21-25 09:40AM	Should Value Investors Buy Donegal Group (DGICA) Stock? (Zacks)
Nov-10-25 09:15AM	Heritage Insurance Holdings, Inc. (HRTG) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-05-25 09:40AM	Has Donegal Group (DGICA) Outpaced Other Finance Stocks This Year? (Zacks)
09:40AM	Are Investors Undervaluing Donegal Group (DGICA) Right Now? (Zacks)
Nov-04-25 08:12PM	Donegal Group Inc (DGICA) Q3 2025 Earnings Call Highlights: Strong Underwriting Performance ... (GuruFocus.com)
06:45AM	Loading…
Oct-30-25 06:45AM	Donegal: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2025 Results (GlobeNewswire)
Oct-29-25 09:51AM	Donegal Group Inc (DGICA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-20-25 09:40AM	Is Donegal Group (DGICA) Stock Undervalued Right Now? (Zacks)
Oct-16-25 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-15-25 10:30AM	Heritage Insurance (HRTG) Moves 10.6% Higher: Will This Strength Last? (Zacks)
09:35AM	Progressive (PGR) Lags Q3 Earnings and Revenue Estimates (Zacks)
Oct-06-25 12:56PM	Donegal Group Inc. Announces Release Date for Third Quarter 2025 Results (GlobeNewswire)
Oct-02-25 09:40AM	Should Value Investors Buy Donegal Group (DGICA) Stock? (Zacks)
Sep-16-25 09:40AM	Are Investors Undervaluing Donegal Group (DGICA) Right Now? (Zacks)
09:15AM	Loading…
Sep-15-25 09:15AM	United Fire Group, Inc (UFCS) Hit a 52 Week High, Can the Run Continue? (Zacks)
Sep-08-25 04:59PM	Is CNA Financial (CNA) Stock Undervalued Right Now? (Zacks)
Sep-04-25 09:28AM	Best Value Stocks to Buy for September 4th (Zacks) +5.87%
Jul-25-25 07:02AM	Donegal: Q2 Earnings Snapshot (Associated Press Finance)
Jul-24-25 06:30AM	Donegal Group Inc. Announces Second Quarter and First Half 2025 Results (GlobeNewswire) -6.16%
Jul-23-25 09:59AM	Earnings To Watch: Donegal Group Inc (DGICA) Reports Q2 2025 Result (GuruFocus.com)
Jul-17-25 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Jul-02-25 03:00PM	Donegal Group Inc. Announces Release Date for Second Quarter 2025 Results (GlobeNewswire)
Apr-26-25 01:53AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 27 (Seeking Alpha)
Apr-25-25 11:09AM	Donegal Group Inc. (DGICA) Q1 2025 Earnings Call Transcript (Seeking Alpha)
Apr-24-25 06:30AM	Donegal Group Inc. Announces First Quarter 2025 Results (GlobeNewswire) +5.39%
Apr-19-25 01:25AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 20 (Seeking Alpha)
Apr-17-25 10:00AM	Donegal Group Inc. Announces Increase in Quarterly Dividend (GlobeNewswire)
Apr-02-25 10:00AM	Donegal Group Inc. Announces Release Date for First Quarter 2025 Results (GlobeNewswire)
Mar-23-25 07:41AM	Is Donegal Group (DGICA) The Stock With The Most Insider Sales In The Last Quarter? (InsiderMonkey)
06:30AM	Loading…
Feb-20-25 06:30AM	Donegal Group Inc. Announces Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Feb-03-25 01:00PM	Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2024 Results (GlobeNewswire)
Dec-19-24 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-24-24 06:30AM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2024 Results (GlobeNewswire) +8.60%
Oct-17-24 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-01-24 03:00PM	Donegal Group Inc. Announces Release Date for Third Quarter 2024 Results (GlobeNewswire)
Sep-25-24 08:05AM	Genpact and Donegal Insurance Group to Elevate Commercial Lines Underwriting Efficiency with Guidewire Solutions (PR Newswire)
Jul-25-24 06:30AM	Donegal Group Inc. Announces Second Quarter and First Half 2024 Results (GlobeNewswire) +5.63%
Jul-18-24 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Jul-01-24 09:00AM	Donegal Group Inc. Announces Release Date for Second Quarter 2024 Results (GlobeNewswire)
May-02-24 01:16PM	AM Best Affirms Credit Ratings of Donegal Insurance Group Members and Donegal Group Inc. (Business Wire)
Apr-25-24 07:45AM	Donegal Group (DGICA) Lags Q1 Earnings Estimates (Zacks)
06:30AM	Donegal Group Inc. Announces First Quarter 2024 Results (GlobeNewswire)
Apr-18-24 10:20AM	Donegal Group Inc. Announces Increase in Quarterly Dividend (GlobeNewswire)
Apr-02-24 01:00PM	Donegal Group Inc. Announces Release Date for First Quarter 2024 Results (GlobeNewswire)
Feb-22-24 06:30AM	Donegal Group Inc. Announces Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-01-24 08:30AM	Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Jan-02-24 09:30AM	Donegal Insurance Group Names Two to Posts of Chief Operating Officer, SVP of Field Operations & National Accounts (GlobeNewswire)
Dec-21-23 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-28-23 12:44PM	Donegal Group Inc. (NASDAQ:DGICA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 06:30AM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2023 Results (GlobeNewswire)
Oct-19-23 03:30PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Sep-27-23 08:00AM	Donegal Group Inc. Announces Release Date for Third Quarter 2023 Results (GlobeNewswire)
Jul-27-23 06:30AM	Donegal Group Inc. Announces Second Quarter and First Half 2023 Results (GlobeNewswire)
Jul-20-23 04:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Jun-27-23 11:00AM	Donegal Group Inc. Announces Release Date for Second Quarter 2023 Results (GlobeNewswire)
Apr-27-23 06:30AM	Donegal Group Inc. Announces First Quarter 2023 Results (GlobeNewswire)
Apr-20-23 10:15AM	Donegal Group Inc. Announces Increase in Quarterly Dividend (GlobeNewswire)
Mar-28-23 03:00PM	Donegal Group Inc. Announces Release Date for First Quarter 2023 Results (GlobeNewswire)
Feb-23-23 06:30AM	Donegal Group Inc. Announces Fourth Quarter and Full Year 2022 Results (GlobeNewswire)
Jan-23-23 01:00PM	Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2022 Results (GlobeNewswire)
Dec-15-22 03:58PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Nov-21-22 08:14AM	One Donegal Group Inc. (NASDAQ:DGIC.A) insider upped their stake by 5.3% in the previous year (Simply Wall St.)
Oct-27-22 06:30AM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2022 Results (GlobeNewswire)
Oct-25-22 07:34AM	Donegal Group Inc.'s (NASDAQ:DGIC.A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Oct-20-22 02:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Sep-28-22 01:00PM	Donegal Group Inc. Announces Release Date for Third Quarter 2022 Results (GlobeNewswire)
Aug-22-22 06:12AM	Investors in Donegal Group (NASDAQ:DGIC.A) have made a return of 27% over the past three years (Simply Wall St.)
Jul-28-22 06:30AM	Donegal Group Inc. Announces Second Quarter and First Half 2022 Results (GlobeNewswire) -10.23%
Jul-21-22 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Jul-04-22 12:06PM	What Type Of Shareholders Own The Most Number of Donegal Group Inc. (NASDAQ:DGIC.A) Shares? (Simply Wall St.)
Jun-29-22 08:00AM	Donegal Insurance Group Taps David Sponic to Lead Personal Lines Division (GlobeNewswire)
Jun-28-22 08:30AM	Donegal Group Inc. Announces Release Date for Second Quarter 2022 Results (GlobeNewswire)
Jun-05-22 10:25AM	Quite a few insiders invested in Donegal Group Inc. (NASDAQ:DGIC.A) last year which is positive news for shareholders (Simply Wall St.)
May-18-22 06:31AM	Is Donegal Group Inc.'s (NASDAQ:DGIC.A) Recent Stock Performance Influenced By Its Fundamentals In Any Way? (Simply Wall St.)
Apr-28-22 07:55AM	Donegal Group (DGICA) Q1 Earnings Beat Estimates (Zacks)
06:30AM	Donegal Group Inc. Announces First Quarter 2022 Results (GlobeNewswire)
Apr-25-22 06:04AM	Donegal Group's (NASDAQ:DGIC.A) Dividend Will Be Increased To US$0.17 (Simply Wall St.)
Apr-21-22 03:01PM	Earnings Preview: Donegal Group (DGICA) Q1 Earnings Expected to Decline (Zacks)
10:00AM	Donegal Group Inc. Announces Increase in Quarterly Dividend (GlobeNewswire)
Apr-18-22 09:16AM	Donegal Insurance Group Names Hudnall as New SVP of Commercial Lines (GlobeNewswire)
Mar-31-22 04:30PM	Donegal Group Inc. Announces Release Date for First Quarter 2022 Results (GlobeNewswire)
09:47AM	AM Best Affirms Credit Ratings for Members of Donegal Insurance Group and Donegal Group Inc. (Business Wire)
Mar-15-22 07:37AM	Shareholders in Donegal Group (NASDAQ:DGIC.A) are in the red if they invested five years ago (Simply Wall St.)
Feb-17-22 05:25PM	Donegal Group (DGICA) Lags Q4 Earnings and Revenue Estimates (Zacks)
04:05PM	Donegal Group Inc. Announces 2021 Fourth Quarter and Full Year Results (GlobeNewswire)
Feb-10-22 03:01PM	Analysts Estimate Donegal Group (DGICA) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jan-25-22 06:28AM	Do Institutions Own Donegal Group Inc. (NASDAQ:DGIC.A) Shares? (Simply Wall St.)
Jan-20-22 03:30PM	Donegal Group Inc. Announces Fourth Quarter 2021 Conference Call and Webcast (GlobeNewswire)
Dec-17-21 05:54AM	Multiple insiders bought Donegal Group Inc. (NASDAQ:DGIC.A) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Dec-16-21 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-28-21 08:31PM	Donegal Group, inc (DGICA) Q3 2021 Earnings Call Transcript (Motley Fool)
Oct-27-21 05:45PM	Donegal Group (DGICA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2021 Results (GlobeNewswire)
Oct-25-21 06:44AM	Why You Might Be Interested In Donegal Group Inc. (NASDAQ:DGIC.A) For Its Upcoming Dividend (Simply Wall St.)
Oct-21-21 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-09-21 09:59AM	Has Donegal Group Inc. (NASDAQ:DGIC.A) Stock's Recent Performance Got Anything to Do With Its Financial Health? (Simply Wall St.)
Sep-28-21 09:00AM	Donegal Group Inc. Announces Third Quarter 2021 Conference Call and Webcast (GlobeNewswire)
Aug-31-21 07:24AM	I Built A List Of Growing Companies And Donegal Group (NASDAQ:DGIC.A) Made The Cut (Simply Wall St.)
Jul-29-21 04:02AM	Donegal Group, inc (DGICA) Q2 2021 Earnings Call Transcript (Motley Fool)

Donegal Group, Inc. is an insurance holding company, which engages in the provision of property and casualty insurance to businesses and individuals. It operates through the following segments: Investment Function, Personal Lines of Insurance, and Commercial Lines of Insurance. The Investment Function segment covers investment activities. The Personal Lines of Insurance segment consists of homeowners and private passenger automobile policies. The Commercial Lines of Insurance segment includes commercial automobile, commercial multi-peril, and workers compensation policies. The company was founded on August 26, 1986 and is headquartered in Marietta, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 26 '25	Buy	20.25	5,000	101,270	13,805,361	Dec 01 08:29 AM
KRAFT KEVIN MICHAEL SR	Director	Nov 25 '25	Option Exercise	14.43	4,500	64,935	17,936	Nov 26 09:21 AM
KRAFT KEVIN MICHAEL SR	Director	Nov 25 '25	Sale	20.02	4,500	90,081	13,436	Nov 26 09:21 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 25 '25	Buy	20.18	8,000	161,417	13,800,361	Nov 26 09:12 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 24 '25	Buy	19.77	8,000	158,130	13,792,361	Nov 26 09:12 AM
KRAFT KEVIN MICHAEL SR	Director	Nov 25 '25	Proposed Sale	20.06	4,500	90,270		Nov 25 12:40 PM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 21 '25	Buy	17.86	51,404	917,948	13,784,361	Nov 24 08:18 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 20 '25	Buy	19.49	8,000	155,898	13,776,361	Nov 24 08:18 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 19 '25	Buy	19.62	7,587	148,845	13,768,361	Nov 20 09:18 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 18 '25	Buy	19.84	7,104	140,953	13,760,774	Nov 20 09:18 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 14 '25	Buy	19.92	8,000	159,357	13,745,670	Nov 18 08:39 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 17 '25	Buy	19.91	8,000	159,262	13,753,670	Nov 18 08:39 AM
SZADY ANNETTE BROOKENS	Director	Nov 13 '25	Option Exercise	14.43	4,500	64,935	7,000	Nov 14 09:53 AM
SZADY ANNETTE BROOKENS	Director	Nov 13 '25	Sale	19.73	4,500	88,767	2,500	Nov 14 09:53 AM
HECKER RICK JOSEPH	SVP & GENERAL COUNSEL	Nov 13 '25	Option Exercise	14.43	900	12,987	900	Nov 14 09:48 AM
HECKER RICK JOSEPH	SVP & GENERAL COUNSEL	Nov 13 '25	Sale	19.74	900	17,762	0	Nov 14 09:48 AM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 13 '25	Option Exercise	15.05	9,617	144,728	105,001	Nov 14 09:43 AM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 12 '25	Option Exercise	14.03	8,383	117,592	103,767	Nov 14 09:43 AM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 13 '25	Sale	19.76	9,617	190,013	95,384	Nov 14 09:43 AM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 12 '25	Sale	19.77	8,383	165,698	95,384	Nov 14 09:43 AM
Moore Sewell Trezevant Jr	Director	Nov 13 '25	Option Exercise	14.43	4,500	64,935	30,655	Nov 14 09:35 AM
Moore Sewell Trezevant Jr	Director	Nov 13 '25	Sale	19.70	4,500	88,671	26,155	Nov 14 09:35 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 13 '25	Buy	19.53	29,000	566,300	13,737,670	Nov 14 09:26 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 12 '25	Buy	19.74	6,794	134,107	13,708,670	Nov 14 09:26 AM
SZADY ANNETTE BROOKENS	Director	Nov 13 '25	Proposed Sale	19.77	4,500	88,965		Nov 13 10:31 AM
Moore Sewell Trezevant Jr	Director	Nov 12 '25	Proposed Sale	19.71	4,500	88,695		Nov 12 03:02 PM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 11 '25	Proposed Sale	19.75	18,000	355,500		Nov 12 08:53 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 10 '25	Buy	19.36	8,000	154,907	13,694,579	Nov 12 08:19 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 07 '25	Buy	19.21	8,000	153,650	13,686,579	Nov 12 08:19 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 11 '25	Buy	19.66	7,297	143,460	13,701,876	Nov 12 08:19 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 06 '25	Buy	19.13	8,000	153,034	13,678,579	Nov 07 08:51 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 05 '25	Buy	19.11	8,000	152,847	13,670,579	Nov 07 08:51 AM
MAHAN JON MARSHALL	Director	Nov 05 '25	Option Exercise	14.43	4,500	64,935	13,988	Nov 05 05:52 PM
MAHAN JON MARSHALL	Director	Nov 05 '25	Sale	19.07	4,500	85,810	9,488	Nov 05 05:52 PM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 04 '25	Buy	18.71	8,000	149,704	13,662,579	Nov 05 05:04 PM
MAHAN JON MARSHALL	Director	Nov 05 '25	Proposed Sale	19.09	4,500	85,900		Nov 05 01:10 PM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 12 '25	Buy	19.53	20,000	390,654	13,654,579	Sep 15 08:29 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 10 '25	Buy	18.99	20,000	379,896	13,618,006	Sep 12 09:08 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 11 '25	Buy	19.45	16,573	322,424	13,634,579	Sep 12 09:08 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 09 '25	Buy	19.24	19,352	372,292	13,598,006	Sep 10 08:53 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 08 '25	Buy	19.10	19,025	363,417	13,578,654	Sep 10 08:53 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 04 '25	Buy	19.22	19,212	369,339	13,559,629	Sep 08 08:59 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 03 '25	Buy	18.37	20,000	367,356	13,540,417	Sep 04 08:14 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 02 '25	Buy	18.27	19,440	355,136	13,520,417	Sep 04 08:14 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Aug 29 '25	Buy	17.84	20,000	356,724	13,500,977	Sep 02 10:27 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Aug 28 '25	Buy	17.61	8,032	141,417	13,480,977	Sep 02 10:27 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Aug 26 '25	Buy	17.45	15,815	275,951	13,457,436	Aug 28 09:22 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Aug 27 '25	Buy	17.49	15,509	271,325	13,472,945	Aug 28 09:22 AM
KING DAVID CHARLES	Director	Aug 27 '25	Option Exercise	14.43	4,500	64,935	7,000	Aug 28 09:17 AM
KING DAVID CHARLES	Director	Aug 27 '25	Sale	17.51	4,500	78,782	2,500	Aug 28 09:17 AM
KING DAVID CHARLES	Director	Aug 27 '25	Proposed Sale	17.50	4,500	78,750		Aug 27 05:06 PM
HESS JACK LEE	Director	Jul 29 '25	Option Exercise	14.57	4,500	65,580	120,920	Jul 30 10:42 AM
VIOZZI VINCENT ANTHONY	Sr. VP & Chief Inv Officer	May 27 '25	Option Exercise	14.39	18,000	259,020	27,316	May 28 08:58 AM
VIOZZI VINCENT ANTHONY	Sr. VP & Chief Inv Officer	May 27 '25	Sale	20.24	19,173	388,120	8,143	May 28 08:58 AM
VIOZZI VINCENT ANTHONY	Officer	May 27 '25	Proposed Sale	20.36	18,000	366,480		May 27 12:40 PM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 23 '25	Option Exercise	14.39	8,696	125,135	10,191	May 27 10:13 AM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 23 '25	Sale	19.78	8,696	171,998	1,495	May 27 10:13 AM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 23 '25	Option Exercise	14.39	8,696	125,135	10,191	May 27 10:10 AM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 23 '25	Sale	19.78	8,696	171,998	1,495	May 27 10:10 AM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 21 '25	Option Exercise	14.39	304	4,375	1,799	May 22 04:57 PM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 21 '25	Sale	20.50	304	6,232	1,495	May 22 04:57 PM
ALTSHULER KRISTI SPENCER	Officer	May 21 '25	Proposed Sale	20.61	12,000	247,320		May 21 10:03 AM
DELAMATER WILLIAM DANIEL	Officer	May 21 '25	Proposed Sale	20.61	9,000	185,490		May 21 10:01 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 19 '25	Option Exercise	14.02	18,000	252,300	18,950	May 20 08:23 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 19 '25	Sale	20.67	18,000	371,988	950	May 20 08:23 AM
FOLMAR WILLIAM ALBERT	Officer	May 19 '25	Proposed Sale	20.60	18,000	370,800		May 19 10:57 AM
PANDEY SANJAY	Sr. VP & Chief Info Officer	May 15 '25	Option Exercise	14.39	12,982	186,811	20,431	May 19 09:11 AM
PANDEY SANJAY	Sr. VP & Chief Info Officer	May 15 '25	Sale	20.27	12,982	263,171	7,449	May 19 09:11 AM
Huber Barry C	Director	May 15 '25	Option Exercise	14.41	9,000	129,690	24,367	May 15 03:30 PM
Huber Barry C	Director	May 15 '25	Sale	20.23	9,000	182,034	15,367	May 15 03:30 PM
SPONIC DAVID WAYNE	Senior Vice President	May 15 '25	Option Exercise	14.39	11,582	166,665	13,588	May 15 03:27 PM
SPONIC DAVID WAYNE	Senior Vice President	May 15 '25	Sale	20.04	11,582	232,103	2,006	May 15 03:27 PM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 15 '25	Option Exercise	14.39	1,150	16,548	2,100	May 15 03:25 PM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 15 '25	Sale	19.89	1,150	22,868	950	May 15 03:25 PM
HAY JEFFERY TIM	Senior Vice President	May 15 '25	Option Exercise	14.07	9,572	134,678	15,684	May 15 03:22 PM
HAY JEFFERY TIM	Senior Vice President	May 15 '25	Sale	20.01	9,572	191,574	6,112	May 15 03:22 PM
Huber Barry C	Director	May 15 '25	Proposed Sale	20.10	9,000	180,900		May 15 03:01 PM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 13 '25	Option Exercise	14.39	12,576	180,969	13,526	May 15 11:22 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 14 '25	Option Exercise	14.39	4,274	61,503	5,224	May 15 11:22 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 13 '25	Sale	19.90	12,576	250,288	950	May 15 11:22 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 14 '25	Sale	19.82	4,274	84,694	950	May 15 11:22 AM
HAY JEFFERY TIM	Senior Vice President	May 13 '25	Option Exercise	14.07	346	4,868	6,458	May 15 11:14 AM
HAY JEFFERY TIM	Senior Vice President	May 13 '25	Sale	20.01	346	6,923	6,112	May 15 11:14 AM
SPONIC DAVID WAYNE	Senior Vice President	May 13 '25	Option Exercise	14.39	418	6,015	2,424	May 15 11:11 AM
SPONIC DAVID WAYNE	Senior Vice President	May 13 '25	Sale	20.01	418	8,363	2,006	May 15 11:11 AM
FOLMAR WILLIAM ALBERT	Officer	May 13 '25	Proposed Sale	19.81	18,000	356,580		May 13 12:23 PM
DONEGAL MUTUAL INSURANCE CO	10% Owner	May 12 '25	Buy	19.83	71,000	1,408,214	13,441,621	May 13 10:05 AM
MILLER JEFFREY DEAN	EVP & Chief Financial Officer	May 12 '25	Option Exercise	14.43	24,000	346,320	47,980	May 13 10:02 AM
MILLER JEFFREY DEAN	EVP & Chief Financial Officer	May 12 '25	Sale	19.83	24,000	476,016	23,980	May 13 10:02 AM
HOFFMAN CHRISTINA MARIE	Sr. VP & Chief Risk Officer	May 12 '25	Option Exercise	14.43	11,000	158,730	15,405	May 13 09:56 AM
HOFFMAN CHRISTINA MARIE	Sr. VP & Chief Risk Officer	May 12 '25	Sale	19.83	11,000	218,174	4,405	May 13 09:56 AM
BURKE KEVIN GERARD	President & Chief Exec Officer	May 12 '25	Option Exercise	14.43	27,000	389,610	38,672	May 13 09:54 AM
BURKE KEVIN GERARD	President & Chief Exec Officer	May 12 '25	Sale	19.83	27,000	535,518	11,672	May 13 09:54 AM
BAWEL DAVID BENJAMIN	SVP & CHIEF ACCOUNTING OFFICER	May 12 '25	Option Exercise	14.43	9,000	129,870	29,417	May 13 09:47 AM
BAWEL DAVID BENJAMIN	SVP & CHIEF ACCOUNTING OFFICER	May 12 '25	Sale	19.83	9,000	178,506	20,417	May 13 09:47 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 09 '25	Option Exercise	14.21	8,236	117,009	31,623	May 13 09:33 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 12 '25	Option Exercise	14.20	5,807	82,451	29,194	May 13 09:33 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 09 '25	Sale	19.87	8,236	163,650	23,387	May 13 09:33 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 12 '25	Sale	19.86	5,807	115,351	23,387	May 13 09:33 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 08 '25	Option Exercise	14.20	14,606	207,457	37,993	May 09 08:45 AM

Open in Screener

KTTA

Pasithea Therapeutics Corp

Dec 01 • 11:11AM ET

1.31

-0.16 -11.00 %

Healthcare • Biotechnology • USA • NASD

KTTA Pasithea Therapeutics Corp daily Stock Chart

Peers: CMPS MNMD ATAI CYBN GHRS RLMD PALI SLS WKSP

| Held by: PSIL VXF

Index	-	P/E	-	EPS (ttm)	-5.08	Insider Own	6.38%	Shs Outstand	7.44M	Perf Week	347.59%
Market Cap	9.74M	Forward P/E	-	EPS next Y	-	Insider Trans	72.78%	Shs Float	6.97M	Perf Month	56.12%
Enterprise Value	5.56M	PEG	-	EPS next Q	-	Inst Own	8.23%	Short Float	0.33%	Perf Quarter	45.58%
Income	-13.49M	P/S	-	EPS this Y	-	Inst Trans	2.66%	Short Ratio	0.00	Perf Half Y	40.68%
Sales	0.00M	P/B	0.80	EPS next Y	-	ROA	-83.64%	Short Interest	0.02M	Perf YTD	-58.47%
Book/sh	1.64	P/C	2.31	EPS next 5Y	-	ROE	-89.90%	52W High	3.85 -66.02%	Perf Year	-56.53%
Cash/sh	0.57	P/FCF	-	EPS past 3/5Y	-88.65% -282.28%	ROIC	-110.55%	52W Low	0.28 365.59%	Perf 3Y	-93.77%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	71.68% 27.55%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	66.41%	Oper. Margin	-	ATR (14)	0.21	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.02	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	68.24	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.02	EPS Q/Q	85.80%	SMA20	78.97%	Beta	0.21	Target Price	40.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	75.86%	Rel Volume	3.16	Prev Close	1.47
Employees	4	LT Debt/Eq	0.00	Earnings	-	SMA200	41.98%	Avg Volume	6.53M	Price	1.31
IPO	Sep 15, 2021	Option/Short	No / No	EPS/Sales Surpr.	-5.88% -33.33%	Trades		Volume	6,101,959	Change	-11.00%

Today 08:38AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -11.00%
Nov-28-25 09:20AM	Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock (GlobeNewswire) +38.68%
Nov-25-25 07:00AM	Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS (GlobeNewswire) +14.78%
Nov-24-25 07:00AM	Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data (GlobeNewswire) +45.33%
Nov-21-25 12:35PM	Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients (GlobeNewswire) -29.58%
04:01PM	Loading…
Nov-20-25 04:01PM	Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study (GlobeNewswire) -12.78%
Nov-04-25 07:03AM	Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients (GlobeNewswire) -5.87%
Sep-16-25 07:03AM	Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients (GlobeNewswire)
Sep-08-25 07:01AM	Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients (GlobeNewswire)
Aug-29-25 08:39AM	Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-28-25 07:02AM	Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire) +11.76%
Jul-31-25 07:01AM	Pasithea Therapeutics Completes Enrollment and Initial Dosing of First Cohort from its Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients (GlobeNewswire)
Jun-11-25 07:02AM	Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board (GlobeNewswire)
Jun-02-25 08:02AM	Pasithea Therapeutics Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004 at the ASCO Annual Meeting 2025 (GlobeNewswire)
May-20-25 07:01AM	Pasithea Therapeutics Announces Preclinical Data that Shows PAS-004 Inhibits ETS2 Signaling, a Key Driver of Inflammation in IBD and Other Large Addressable Market Diseases (GlobeNewswire)
07:02AM	Loading…
May-14-25 07:02AM	Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First Clinical Trial Site (GlobeNewswire) +11.07%
May-07-25 05:00PM	Pasithea Therapeutics Announces Closing of $5 Million Public Offering (GlobeNewswire) -25.66% -15.04%
11:35AM	Pasithea Therapeutics 3.57M share Secondary priced at $1.40 (TipRanks)
May-06-25 11:10AM	Pasithea Therapeutics Announces Pricing of $5 Million Public Offering (GlobeNewswire) +7.04%
07:03AM	Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004 (GlobeNewswire)
Apr-29-25 07:02AM	Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients (GlobeNewswire)
Apr-24-25 07:02AM	Pasithea Therapeutics to Present Updated Data from Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients at the 2025 ASCO Annual Meeting (GlobeNewswire) +5.52%
Apr-10-25 07:02AM	Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer (GlobeNewswire) +46.79%
Mar-24-25 06:59AM	Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference (GlobeNewswire)
Feb-05-25 06:59AM	Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer (GlobeNewswire) +31.73%
Jan-14-25 08:02AM	Pasithea Therapeutics Announces Opening of European Clinical Trial Sites and Completes Initial Dosing of Cohort 4 (GlobeNewswire)
Nov-20-24 07:02AM	Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer (GlobeNewswire)
Sep-26-24 06:44PM	Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) +52.15%
07:02AM	Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer (GlobeNewswire)
Sep-09-24 08:01AM	Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies (GlobeNewswire)
08:02AM	Loading…
Sep-03-24 08:02AM	Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board (GlobeNewswire) +6.57%
Aug-28-24 09:11AM	Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Jun-25-24 12:52PM	KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q4 2023 (InvestorPlace) +6.64%
Jun-13-24 06:59AM	Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for PAS-004 in Ongoing Phase 1 Clinical Trial (GlobeNewswire)
May-28-24 06:59AM	Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting (GlobeNewswire)
May-15-24 09:53AM	KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q1 2024 (InvestorPlace)
Apr-29-24 07:59AM	Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting (GlobeNewswire)
Apr-24-24 07:59AM	Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers (GlobeNewswire)
Apr-15-24 11:00AM	11 Undervalued Stocks for Less Than $50 in April 2024 (Investopedia)
Feb-13-24 07:59AM	Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004 (GlobeNewswire) +8.95%
Jan-08-24 07:59AM	Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position (GlobeNewswire) +5.03%
Jan-02-24 08:35AM	Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients (GlobeNewswire) +8.78%
Dec-28-23 05:00PM	Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023 (GlobeNewswire) -5.13%
Dec-19-23 05:19PM	Pasithea Therapeutics Announces Results from 2023 Annual Meeting (GlobeNewswire) -6.06% -13.61%
Dec-13-23 09:03AM	Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today? (InvestorPlace)
Dec-11-23 11:18AM	Why Is Pasithea Therapeutics (KTTA) Stock Up 105% Today? (InvestorPlace) +47.42%
08:01AM	Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models (GlobeNewswire)
Nov-29-23 04:27PM	Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders (GlobeNewswire) +6.63% -7.91%
07:59AM	Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development (GlobeNewswire)
Nov-09-23 07:59AM	Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets 5 1 Integrin for the Treatment of both Sporadic and Familial ALS (GlobeNewswire)
Sep-14-23 08:30AM	Pasithea Therapeutics Corp. Announces Final Results of Tender Offer (GlobeNewswire)
Sep-07-23 04:14PM	Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) -13.18%
Aug-01-23 07:59AM	Pasithea Therapeutics publishes study in Proceedings of the National Academy of Sciences (PNAS) that shows an increase in 5 integrin expression in ALS human and mouse brain tissue, and further demonstrates targeting 5 integrin results in improved survival and motor function (GlobeNewswire)
Jul-31-23 06:00AM	The Psychedelics Stock Universe Is Shrinking, Despite the Hype (Bloomberg)
Jul-20-23 08:43AM	Pasithea Therapeutics Announces Intention to Commence a $4.0 Million Tender Offer for its Common Stock at Price of $0.70 per Share in Cash (GlobeNewswire) +25.88%
08:40AM	Pasithea Therapeutics Special Committee Rejects Unsolicited Bid from Lucy Scientific Discovery, Inc. (GlobeNewswire)
Jul-13-23 09:14AM	Lucy Scientific Scores Richard Nanula as CEO After Senior Roles at Disney, Amgen, Starwood (Exec Edge)
Jun-30-23 09:28AM	Pasithea Therapeutics Confirms Previous Creation of Independent Special Committee of its Board of Directors (GlobeNewswire)
Jun-29-23 02:50PM	Lucy Scientific Discovery Reiterates Its Proposal to Acquire Pasithea Therapeutics Corp. (GlobeNewswire) +11.24%
08:29AM	Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004 (GlobeNewswire)
Jun-06-23 04:30PM	Pasithea Therapeutics Confirms Receipt of Unsolicited Proposal from Lucy Scientific Discovery Inc. (GlobeNewswire)
Jun-05-23 09:00AM	Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics Corp. (GlobeNewswire) +25.00%
Jun-01-23 07:57AM	Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference (GlobeNewswire)
May-14-23 08:13AM	Pasithea Therapeutics First Quarter 2023 Earnings: US$0.13 loss per share (vs US$0.068 loss in 1Q 2022) (Simply Wall St.)
May-03-23 08:26AM	Pasithea Therapeutics to Participate in EF Hutton Inaugural Global Conference (GlobeNewswire)
Mar-02-23 08:00AM	Pasithea Therapeutics Chairman, Prof. Lawrence Steinman, to Deliver Keynote Address at the American Association for Advancement of Science (AAAS) Annual Meeting (GlobeNewswire)
Feb-23-23 08:00AM	Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Deliver Dr. Kenneth P. Johnson Lecture at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) (GlobeNewswire) -5.64%
Feb-16-23 07:30AM	Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Receive Pioneer in Medicine Award (GlobeNewswire)
Jan-18-23 08:00AM	Pasithea Therapeutics Signs CMC Development and Manufacturing Agreement for the Production of PAS-004 (GlobeNewswire)
Dec-14-22 05:18PM	Majority of Stockholders Support Pasithea Directors at Special Meeting (GlobeNewswire)
Dec-12-22 07:00AM	Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group (GlobeNewswire) -8.22%
Dec-07-22 04:00PM	Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics (Business Wire)
Dec-06-22 08:00AM	Pasithea Therapeutics to Present at Annual Meeting of the Antibody Society Conference (GlobeNewswire)
Nov-28-22 07:05PM	Pasithea Therapeutics Postpones Special Meeting until December 9, 2022 at 9:00 AM Eastern Time (GlobeNewswire)
Nov-22-22 04:00PM	Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics (Business Wire)
Oct-27-22 09:50AM	A New BioTech Research Race Is Focused On Improving Life For MS Patients (News Direct)
Oct-17-22 08:00AM	Pasithea Therapeutics to Present Tolerizing Vaccine Program Results at Immunotherapy 2022 International Course and Symposium (GlobeNewswire) -11.20%
Oct-14-22 09:48AM	Pasithea' Largest Investor Group Says AlloMek Therapeutics Deal Ill-timed, Highly Dilutive (Benzinga)
Oct-13-22 04:00PM	Investor Group Comments on Pasithea Therapeutics Seemingly Defensive and Ill-Timed Acquisition of AlloMek Therapeutics (Business Wire)
Oct-12-22 08:00AM	Pasithea Therapeutics Acquires AlloMek Therapeutics (GlobeNewswire)
07:31AM	EXCLUSIVE: Pasithea Bolsters CNS-Focused Pipeline With AlloMek Therapeutics Acquisition (Benzinga)
Oct-10-22 09:39AM	New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope (News Direct)
Oct-03-22 06:03PM	Pasithea Therapeutics to Call Special Meeting of Stockholders (GlobeNewswire)
09:09AM	Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis (News Direct)
Sep-28-22 09:00AM	Investor Group Sends Letter to Pasithea Therapeutics Board of Directors (Business Wire)
Sep-20-22 08:00AM	Pasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors (GlobeNewswire)
Sep-15-22 08:00AM	Pasithea Therapeutics Further Strengthens its Scientific Advisory Board with the Appointment of Dr. Merit Cudkowicz (GlobeNewswire)
Sep-12-22 11:53AM	Here's Why We're Not Too Worried About Pasithea Therapeutics' (NASDAQ:KTTA) Cash Burn Situation (Simply Wall St.)
Sep-09-22 10:32AM	Pasithea Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Sep-06-22 09:30AM	Investor Group Successful in Request to Call Special Meeting of Stockholders of Pasithea Therapeutics (Business Wire)
Aug-24-22 08:00AM	Investor Group Urges Stockholders of Pasithea Therapeutics to Vote to Call Special Meeting (Business Wire)
Aug-18-22 08:00AM	Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference (GlobeNewswire)
Aug-11-22 08:00AM	Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis (GlobeNewswire) +6.83%
07:30AM	EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With Potential In Monkeypox (Benzinga)
Aug-05-22 09:00AM	Investor Group Urges Stockholders of Pasithea Therapeutics Corp. to Call Special Meeting (Business Wire)
Aug-02-22 07:00AM	Pasithea Therapeutics Urges Stockholders to Reject Activist Camac Groups Unjustified Campaign (GlobeNewswire)
Jul-14-22 08:00AM	Pasithea Therapeutics Awarded a Drug Development Research Grant (GlobeNewswire)
Jun-23-22 09:00AM	Investor Group Comments on Pasithea Therapeutics Seemingly Defensive and Dilutive Related-Party Acquisition of Alpha-5 (Business Wire)
08:00AM	Pasithea Therapeutics to Participate in the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond (GlobeNewswire)
Jun-22-22 08:00AM	Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC (GlobeNewswire)

Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STEINMAN LAWRENCE	Director	Nov 28 '25	Buy	0.75	133,333	100,000	199,691	Dec 01 09:07 AM
Marques Tiago	Chief Executive Officer	Nov 28 '25	Buy	0.75	33,333	25,000	73,334	Dec 01 08:56 AM
Dumesnil Simon	Director	Nov 28 '25	Buy	0.75	33,333	25,000	35,833	Dec 01 08:54 AM
Tiago Reis Marques	Officer, Director	May 12 '25	Proposed Sale	0.83	960	798		May 14 09:55 PM
Marques Tiago	Chief Executive Officer	May 12 '25	Sale	0.82	960	792	40,001	May 14 09:55 PM

Open in Screener

MAIA

MAIA Biotechnology Inc

Dec 01 • 11:11AM ET

1.27

+0.09 7.87 %

Healthcare • Biotechnology • USA • AMEX

MAIA MAIA Biotechnology Inc daily Stock Chart

Peers: PDSB FATE AVXL IONS AFMD PTGX ONCT BCLI ADMA VSTM

Index	-	P/E	-	EPS (ttm)	-0.74	Insider Own	21.86%	Shs Outstand	34.45M	Perf Week	39.65%
Market Cap	47.14M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	2.99%	Shs Float	28.93M	Perf Month	-2.83%
Enterprise Value	36.25M	PEG	-	EPS next Q	-0.13	Inst Own	6.41%	Short Float	3.28%	Perf Quarter	-15.14%
Income	-22.34M	P/S	-	EPS this Y	50.17%	Inst Trans	0.72%	Short Ratio	1.76	Perf Half Y	-27.26%
Sales	0.00M	P/B	1051.98	EPS next Y	6.76%	ROA	-212.50%	Short Interest	0.95M	Perf YTD	-35.71%
Book/sh	0.00	P/C	4.33	EPS next 5Y	-	ROE	-2691.06%	52W High	2.74 -53.54%	Perf Year	-42.66%
Cash/sh	0.29	P/FCF	-	EPS past 3/5Y	3.77% -11.40%	ROIC	-53610.15%	52W Low	0.87 46.31%	Perf 3Y	-64.44%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.79% 8.33%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	44.50%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.18	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	58.12	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.18	EPS Q/Q	-134.24%	SMA20	20.17%	Beta	0.01	Target Price	14.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-4.60%	Rel Volume	17.96	Prev Close	1.18
Employees	13	LT Debt/Eq	0.00	Earnings	Nov 04	SMA200	-21.53%	Avg Volume	540.21K	Price	1.27
IPO	Jul 28, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	2,872,490	Change	7.87%

Today 09:17AM	MAIA Biotechnology Announces Open Market Purchases by CEO and Directors (GlobeNewswire) +7.87%
Nov-21-25 09:01AM	MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025 (GlobeNewswire)
Nov-20-25 08:47AM	MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania's 2025 Smart Diaspora Conference on Oncology Research and Innovation (GlobeNewswire) -5.33%
Oct-27-25 10:45AM	MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Oct-23-25 08:36AM	MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer (GlobeNewswire) +7.35%
04:20PM	Loading…
Oct-13-25 04:20PM	MAIA Biotechnology Announces $736,600 Private Placement (GlobeNewswire) -6.37%
Oct-07-25 03:13PM	Cancer drug maker takes sudden pivot into crypto (TheStreet)
08:47AM	MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets (GlobeNewswire)
Sep-29-25 04:30PM	MAIA Biotechnology Announces $2.25 Million Private Placement (GlobeNewswire)
Sep-24-25 08:01AM	MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent (GlobeNewswire)
Sep-12-25 08:33AM	Maias NSCLC immunotherapy secures Phase II efficacy win (Clinical Trials Arena)
Sep-11-25 09:27AM	MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer (GlobeNewswire) +8.97%
Sep-05-25 09:03AM	MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer (GlobeNewswire)
Aug-27-25 09:01AM	MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells (GlobeNewswire) +7.14%
Aug-18-25 08:00AM	Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) (GlobeNewswire)
09:01AM	Loading…
Aug-13-25 09:01AM	MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy (GlobeNewswire)
Jul-28-25 08:01AM	MAIA Biotechnology Receives FDAs Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer (Business Wire)
Jul-17-25 09:17AM	MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy (Business Wire)
Jul-10-25 10:40AM	MAIA Biotechnology doses first patient in expansion of Phase II lung cancer trial (Clinical Trials Arena)
Jul-09-25 09:15AM	MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer (Business Wire) +9.24%
Jul-01-25 09:00AM	MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress (Business Wire) +6.67%
Jun-24-25 08:15AM	MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board (Business Wire)
Jun-19-25 09:25AM	MAIA Biotechnology, Roche sign supply agreement for cancer therapies (TipRanks)
Jun-18-25 09:15AM	MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies (Business Wire) +8.43%
Jun-10-25 08:46AM	MAIA Biotechnology to Present at BIO International Convention 2025 (Business Wire)
Jun-05-25 02:28PM	MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients (Benzinga) +10.80%
11:10AM	MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial (Business Wire)
08:04AM	MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer (Business Wire)
May-27-25 08:29PM	MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial (Insider Monkey)
05:35PM	CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000 (Business Wire)
11:05AM	Loading…
May-15-25 11:05AM	MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting (Business Wire)
May-14-25 10:15AM	MAIA Biotechnology Announces Director Participation in Recent Private Placement (Business Wire)
May-06-25 10:00AM	Best Momentum Stocks to Buy for May 6th (Zacks) +7.85%
07:41AM	New Strong Buy Stocks for May 6th (Zacks)
May-05-25 11:45PM	CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement (Business Wire) -6.83%
04:05PM	MAIA Biotechnology Announces $1.08 Million Private Placement (Business Wire)
Apr-01-25 08:30AM	MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders (Business Wire)
Mar-28-25 10:39AM	Is MAIA Biotechnology, Inc. (MAIA)he Cheapest Stock Insiders Are Buying In March? (Insider Monkey)
Mar-27-25 12:00PM	MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know (Zacks)
Mar-25-25 08:46AM	MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025 (Business Wire) -5.99%
Mar-20-25 09:20AM	MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug (Business Wire)
Mar-19-25 11:00AM	MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO (Business Wire)
Feb-27-25 08:51AM	MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients (Business Wire) +7.07%
Feb-26-25 08:47AM	MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer (Business Wire) +5.75%
Feb-24-25 04:30PM	MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million (Business Wire)
Feb-18-25 03:44PM	MAIA Biotechnology Announces Private Placement of $2,715,000 (Business Wire)
Feb-04-25 08:51AM	MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer (Business Wire) +5.82%
Jan-10-25 09:45AM	MAIA Biotechnology to Present at Biotech Showcase 2025 (Business Wire)
Jan-07-25 09:12AM	MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications (Business Wire) +15.53%
Dec-19-24 08:47AM	MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings (Business Wire) +5.15%
Dec-16-24 08:37AM	MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas (Business Wire) +10.00%
Dec-09-24 06:00PM	MAIA Biotechnology Announces Private Placement of Approximately $950,000 (Business Wire)
Dec-03-24 08:17AM	MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer (Business Wire)
Nov-07-24 08:47AM	MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement (Business Wire)
Nov-05-24 09:45AM	MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting (Business Wire) +6.25%
Oct-28-24 07:00PM	MAIA Biotechnology Announces $2.44 Million Private Placement (Business Wire) +8.37%
Oct-15-24 08:15AM	MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics (Business Wire)
Sep-10-24 06:00AM	MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer (Business Wire) -5.75%
Sep-04-24 08:30AM	MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire) +15.75%
Jul-23-24 04:11AM	MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent (Business Wire)
Jun-07-24 12:31PM	MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDAs Approval of a Telomerase Inhibitor Agent Therapy (Business Wire) +16.27%
Jun-06-24 10:07AM	MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent (Business Wire)
Jun-04-24 08:41AM	MAIA Biotechnology Reveals New Clinical Data Showing THIOs Strong Efficacy in Non-Small Cell Lung Cancer (Business Wire) -26.27%
May-17-24 08:37AM	MAIA Biotechnology to Present at the BIO International Convention 2024 (Business Wire) +6.09%
May-16-24 08:37AM	MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting (Business Wire) +8.71%
Apr-30-24 08:08AM	MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement (Business Wire) -8.72%
Apr-29-24 08:08AM	MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement (Business Wire) +9.18%
Apr-23-24 08:51AM	MAIA Biotechnology Announces $1.00 Million Private Placement (Business Wire) +8.85%
Apr-05-24 08:01AM	MAIA Biotechnology to Present at Two Investor Conferences in April 2024 (Business Wire) +6.82%
Mar-28-24 03:00PM	MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero (Business Wire) -11.29%
Mar-26-24 03:00PM	MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement (Business Wire)
08:01AM	MAIA Biotechnology Announces $1.33 Million Private Placement (Business Wire)
Mar-22-24 03:00PM	MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement (Business Wire) +8.76%
Mar-21-24 03:00PM	MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board (Business Wire) +17.58%
Mar-16-24 01:49AM	Director Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA) (GuruFocus.com)
Mar-07-24 09:45AM	MAIA Biotechnology to Participate in the 36th Annual ROTH Conference (Business Wire)
Mar-06-24 11:04AM	MAIA Biotechnology and Nationwide Childrens Hospital Announce Presentation of THIOs Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting (Business Wire)
08:48AM	MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients (Business Wire)
Mar-05-24 08:45AM	MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders (Business Wire)
Feb-27-24 10:30AM	MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor (GlobeNewswire)
Feb-22-24 10:30AM	MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer (GlobeNewswire)
Feb-07-24 08:01AM	MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer (Business Wire)
Jan-24-24 07:15AM	MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds (Business Wire)
Jan-17-24 09:00AM	MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024 (Business Wire) +20.33%
Jan-05-24 08:00AM	MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024 (Business Wire) +26.89%
Dec-19-23 07:00AM	MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer (Business Wire)
Dec-01-23 09:55AM	Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now (Zacks)
Nov-17-23 03:52PM	MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering (Business Wire) -13.57%
09:00AM	MAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancer (ACCESSWIRE)
Nov-15-23 09:35AM	MAIA Biotechnology Announces $4 Million Registered Direct Offering (Business Wire) -24.73%
Nov-10-23 07:01AM	FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma (Business Wire)
Nov-07-23 09:01AM	MAIA Biotechnology Inc (MAIA) Reports Q3 2023 Financial Results and Progress in Anticancer ... (GuruFocus.com)
08:15AM	MAIA Biotechnology Reports Third Quarter 2023 Financial Results and Highlights Recent Development Progress for Anticancer Asset THIO (Business Wire)
Oct-31-23 09:00AM	MAIA Biotechnology Reports Positive Phase 2 Clinical Trial Data On Its Treatment For Non-Small Cell Lung Cancer (ACCESSWIRE)
Oct-30-23 08:41AM	MAIA Biotechnology Reveals Higher Anticancer Potency of Telomere-Targeting Compounds Derived from THIO (Business Wire) +5.82%
Oct-24-23 08:00AM	MAIA Biotechnology Announces 100% Disease Control in Second-Line Non-Small Cell Lung Cancer Demonstrating Impressive Positive Preliminary Efficacy Data for Ongoing THIO-101 Phase 2 Trial (Business Wire)
Oct-19-23 08:35AM	MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 Phase 2 Clinical Trial at European Society for Medical Oncology Congress 2023 (Business Wire)
Oct-17-23 09:00AM	MAIA Biotechnology's THIO Emerges As Potential Breakthrough In Pediatric Brain Cancer Therapy (ACCESSWIRE) -5.06%
08:01AM	MAIA Biotechnology to Present Latest Findings for Second Generation THIO Program at Turkish Biochemical Societys International Biochemistry Congress 2023 (Business Wire)
Oct-12-23 09:20AM	MAIA Biotechnology Reveals New Data Showing THIOs Potent Anticancer Activity in Aggressive Pediatric Brain Cancer (Business Wire)

MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vitoc Vlad	Chief Executive Officer	Nov 28 '25	Buy	1.14	50,000	56,830	881,421	Dec 01 06:20 AM
Vitoc Vlad	Chief Executive Officer	Nov 26 '25	Buy	1.05	22,000	23,019	853,421	Dec 01 06:20 AM
Luput Cristian	Director	Nov 26 '25	Buy	1.08	20,000	21,616	419,483	Dec 01 06:18 AM
Luput Cristian	Director	Nov 28 '25	Buy	1.11	18,145	20,230	437,628	Dec 01 06:18 AM
Smith Stan	Director	Nov 26 '25	Buy	1.04	15,000	15,582	1,364,289	Dec 01 06:14 AM
Luput Cristian	Director	Nov 25 '25	Buy	0.98	10,000	9,785	399,483	Nov 28 06:52 AM
Vitoc Vlad	Chief Executive Officer	Nov 25 '25	Buy	0.97	10,500	10,144	831,421	Nov 28 06:48 AM
Smith Stan	Director	Nov 25 '25	Buy	0.98	15,000	14,700	1,349,289	Nov 26 04:43 PM
Smith Stan	Director	Nov 24 '25	Buy	0.99	10,000	9,900	1,334,289	Nov 26 04:43 PM
Vitoc Vlad	Chief Executive Officer	Nov 24 '25	Buy	0.99	10,000	9,891	820,921	Nov 25 04:15 PM
Vitoc Vlad	Chief Executive Officer	Nov 21 '25	Buy	0.92	1,800	1,656	810,921	Nov 25 04:15 PM
Smith Stan	Director	Oct 01 '25	Buy	1.30	19,230	24,999	1,324,289	Oct 02 04:51 PM
Smith Stan	Director	Jun 03 '25	Buy	1.50	33,333	50,000	1,305,059	Jun 05 04:42 PM
Guerrero Ramiro	Director	May 08 '25	Buy	1.50	20,000	30,000	588,218	May 12 04:14 PM
Smith Stan	Director	May 08 '25	Buy	1.50	66,666	99,999	1,271,726	May 12 04:12 PM
Guerrero Ramiro	Director	Mar 03 '25	Buy	1.50	33,333	50,000	568,218	Mar 05 04:42 PM
Smith Stan	Director	Mar 03 '25	Buy	1.50	25,000	37,500	1,205,060	Mar 05 04:40 PM
Guerrero Ramiro	Director	Feb 24 '25	Buy	1.50	73,333	110,000	534,885	Feb 25 04:11 PM
Smith Stan	Director	Feb 24 '25	Buy	1.50	50,000	75,000	1,180,060	Feb 25 04:10 PM
Smith Stan	Director	Dec 13 '24	Buy	1.87	25,000	46,800	1,130,060	Dec 13 05:17 PM
Guerrero Ramiro	Director	Dec 13 '24	Buy	1.87	53,418	99,998	514,970	Dec 13 05:15 PM

Open in Screener

SUNC

SunocoCorp LLC

Dec 01 • 11:11AM ET

52.44

-0.32 -0.61 %

Energy • Oil & Gas Midstream • USA • NYSE

Held by: ESML DFIS IDEV DFIC IXUS FENY PIPE DFAX DFAI AVDE

Index	-	P/E	-	EPS (ttm)	-	Insider Own	0.01%	Shs Outstand	42.95M	Perf Week	0.47%
Market Cap	2.25B	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	42.95M	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	1.00	Inst Own	-	Short Float	1.49%	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.39	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.64M	Perf YTD	5.42%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	53.79 -2.52%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	47.00 11.57%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	2.23% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	1.70	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	64.86	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-29.22%	SMA20	3.27%	Beta	-	Target Price	63.50
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	3.27%	Rel Volume	0.18	Prev Close	52.76
Employees	-	LT Debt/Eq	-	Earnings	Sep 03	SMA200	3.27%	Avg Volume	1.63M	Price	52.44
IPO	Nov 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	88,947	Change	-0.61%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-17-25	Initiated	Raymond James	Outperform
Nov-11-25	Initiated	Citigroup	Buy	$65

Nov-12-25 09:35AM	DraftKings downgraded, Instacart upgraded: Wall Streets top analyst calls (TipRanks)
Nov-11-25 09:32AM	DraftKings downgraded, Instacart upgraded: Wall Street's top analyst calls (The Fly)
09:06AM	Here are Tuesdays Top Wall Street Analyst Research Calls: Coreweave, Instacart, Qorvo, Robinhood Markets, Skyworks Solutions, Viasat and More (24/7 Wall St.)
Nov-07-25 02:12PM	LNG Export Demand Driving Natural Gas to Highs: 5 Strong Buy Dividend Leaders (24/7 Wall St.)
Nov-06-25 12:02PM	Sunoco LP (SUN) Q3 2025 Earnings Call Highlights: Record EBITDA and Strategic Acquisition ... (GuruFocus.com)

SunocoCorp LLC engages in operating crude oil pipelines and terminals. The company was founded on June 6, 2000 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jennings Michael	Director	Nov 26 '25	Buy	52.00	1,000	52,000	8,590	Dec 01 08:00 AM
Jennings Michael	Director	Nov 17 '25	Buy	49.68	3,000	149,037	7,590	Nov 18 09:14 AM

Open in Screener

SND

Smart Sand Inc

Dec 01 • 11:11AM ET

3.14

+0.19 6.61 %

Energy • Oil & Gas Equipment & Services • USA • NASD

Peers: PTEN HP LBRT RES NBR PUMP HTO

| Held by: VTI VXF BSVO ONEQ DFAT IWC DFAC DFSV DFAS DCOR

Index	-	P/E	32.16	EPS (ttm)	0.10	Insider Own	30.12%	Shs Outstand	38.90M	Perf Week	13.54%
Market Cap	136.94M	Forward P/E	-	EPS next Y	-	Insider Trans	0.65%	Shs Float	30.43M	Perf Month	46.96%
Enterprise Value	170.45M	PEG	-	EPS next Q	-	Inst Own	26.77%	Short Float	0.39%	Perf Quarter	62.11%
Income	3.90M	P/S	0.41	EPS this Y	-	Inst Trans	-0.23%	Short Ratio	0.86	Perf Half Y	77.76%
Sales	335.47M	P/B	0.51	EPS next Y	-	ROA	1.15%	Short Interest	0.12M	Perf YTD	46.95%
Book/sh	6.17	P/C	26.96	EPS next 5Y	-	ROE	1.61%	52W High	3.00 4.83%	Perf Year	40.10%
Cash/sh	0.12	P/FCF	12.11	EPS past 3/5Y	- -37.20%	ROIC	1.48%	52W Low	1.69 85.67%	Perf 3Y	69.79%
Dividend Est.	-	EV/EBITDA	5.41	Sales past 3/5Y	34.97% 5.96%	Gross Margin	11.23%	Volatility	5.52% 5.68%	Perf 5Y	80.40%
Dividend TTM	-	EV/Sales	0.51	EPS Y/Y TTM	170.49%	Oper. Margin	0.30%	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	Dec 02, 2025	Quick Ratio	1.06	Sales Y/Y TTM	18.98%	Profit Margin	1.16%	RSI (14)	83.92	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.70	EPS Q/Q	3184.00%	SMA20	23.14%	Beta	0.39	Target Price	3.00
Payout	0.00%	Debt/Eq	0.16	Sales Q/Q	46.90%	SMA50	36.33%	Rel Volume	4.21	Prev Close	2.95
Employees	285	LT Debt/Eq	0.10	Earnings	Nov 12 BMO	SMA200	52.65%	Avg Volume	138.25K	Price	3.14
IPO	Nov 04, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	172,096	Change	6.61%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-29-21	Upgrade	Evercore ISI	Underperform → In-line	$4
Mar-09-20	Downgrade	Evercore ISI	In-line → Underperform
Jul-17-19	Upgrade	B. Riley FBR	Neutral → Buy	$4.50 → $5
Mar-20-19	Initiated	B. Riley FBR	Neutral	$4.50
Nov-13-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-12-18	Downgrade	Credit Suisse	Neutral → Underperform
Oct-17-18	Downgrade	Jefferies	Hold → Underperform
Jun-26-18	Downgrade	Johnson Rice	Buy → Hold
Jun-08-18	Downgrade	Tudor Pickering	Buy → Hold
Jan-02-18	Downgrade	Janney	Buy → Neutral
Dec-08-17	Initiated	Seaport Global Securities	Buy	$15
Nov-15-17	Downgrade	Jefferies	Buy → Hold
Oct-10-17	Initiated	Deutsche Bank	Buy	$9
Jul-20-17	Downgrade	Credit Suisse	Outperform → Neutral
Jun-15-17	Initiated	Janney	Buy	$13
Mar-17-17	Upgrade	Johnson Rice	Accumulate → Buy	$20 → $21
Jan-20-17	Downgrade	Goldman	Buy → Neutral
Jan-09-17	Initiated	Johnson Rice	Accumulate	$20
Dec-13-16	Initiated	Jefferies	Buy	$18
Dec-07-16	Initiated	Tudor Pickering	Buy

Show Previous Ratings

Nov-25-25 12:33AM	Smart Sand (SND) Gained Over 10% This Week. Here is Why (Insider Monkey)
Nov-18-25 04:00PM	SMART SAND, INC. DECLARES SPECIAL DIVIDEND OF $0.05 PER SHARE (PR Newswire)
Nov-12-25 07:44AM	Smart Sand, Inc. Announces Third Quarter 2025 Results (PR Newswire)
06:26AM	Smart Sand: Q3 Earnings Snapshot (Associated Press Finance)
Sep-23-25 08:00AM	SMART SAND, INC. TO PARTICIPATE IN THE LYTHAM PARTNERS FALL 2025 INVESTOR CONFERENCE ON SEPTEMBER 30, 2025 (PR Newswire)
04:17PM	Loading…
Aug-12-25 04:17PM	Smart Sand: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Smart Sand, Inc. Announces Second Quarter 2025 Results (PR Newswire)
Aug-04-25 08:47AM	SMART SAND, INC. ANNOUNCES TIMING OF SECOND QUARTER 2025 EARNINGS RELEASE (PR Newswire)
Jul-23-25 04:00PM	SMART SAND, INC. DECLARES SPECIAL DIVIDEND OF $0.10 PER SHARE (PR Newswire) +8.85%
May-13-25 04:10PM	Smart Sand: Q1 Earnings Snapshot (Associated Press Finance) -7.87%
04:00PM	Smart Sand, Inc. Announces First Quarter 2025 Results (PR Newswire)
May-07-25 01:11PM	Smart Sand, Inc. (SND): A Bull Case Theory (Insider Monkey)
Apr-30-25 04:07PM	SMART SAND, INC. ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE (PR Newswire)
Apr-18-25 09:40AM	Should Value Investors Buy Smart Sand (SND) Stock? (Zacks)
Mar-18-25 04:00PM	SMART SAND, INC. TO PRESENT AT THE SIDOTI VIRTUAL INVESTOR CONFERENCE ON MARCH 19-20, 2025 (PR Newswire)
09:00AM	Loading…
09:00AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-04-25 05:12AM	Smart Sand: Q4 Earnings Snapshot (Associated Press Finance)
Mar-03-25 08:36PM	Smart Sand, Inc. Announces Fourth Quarter 2024 and Full Year 2024 Results (PR Newswire)
Feb-28-25 07:17AM	Smart Sand Inc (SND) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-24-25 04:07PM	SMART SAND, INC. ANNOUNCES TIMING OF FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE (PR Newswire)
Dec-04-24 09:40AM	Are Investors Undervaluing Smart Sand (SND) Right Now? (Zacks)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESS Newswire)
Nov-18-24 09:40AM	Should Value Investors Buy Smart Sand (SND) Stock? (Zacks)
Nov-15-24 09:40AM	Is Smart Sand (SND) Outperforming Other Oils-Energy Stocks This Year? (Zacks)
Nov-14-24 02:12AM	Smart Sand Inc (SND) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Market Challenges (GuruFocus.com) +6.91%
Nov-12-24 05:10PM	Smart Sand (SND) Reports Break-Even Earnings for Q3 (Zacks) -17.49%
04:04PM	Smart Sand: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Smart Sand, Inc. Announces Third Quarter 2024 Results (PR Newswire)
Nov-11-24 07:22AM	Smart Sand Inc (SND) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com) +5.53%
Oct-31-24 09:40AM	Are Investors Undervaluing Smart Sand (SND) Right Now? (Zacks)
04:00PM	Loading…
Oct-29-24 04:00PM	SMART SAND, INC. ANNOUNCES TIMING OF THIRD QUARTER 2024 EARNINGS RELEASE AND INVESTOR CONFERENCE CALL (PR Newswire)
Oct-15-24 09:40AM	Is Smart Sand (SND) Stock Undervalued Right Now? (Zacks)
Oct-09-24 06:23PM	Smart Sand Inc (SND) Q2 2024 Earnings Call Highlights: Navigating Revenue Decline with Strong ... (GuruFocus.com)
Oct-04-24 04:31PM	Smart Sand Enhances Shareholder Returns with Dividend and Buyback (TipRanks) +10.50%
Oct-03-24 04:00PM	SMART SAND, INC. DECLARES SPECIAL DIVIDEND OF $0.10 PER SHARE AND AUTHORIZES SHARE REPURCHASE PROGRAM (PR Newswire)
Aug-13-24 07:56PM	Smart Sand, Inc. Announces Second Quarter 2024 Results (PR Newswire) +6.45%
06:00PM	Smart Sand (SND) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:55PM	Smart Sand: Q2 Earnings Snapshot (Associated Press Finance)
Jul-26-24 04:22PM	SMART SAND, INC. ANNOUNCES TIMING OF SECOND QUARTER 2024 EARNINGS RELEASE AND INVESTOR CONFERENCE CALL (PR Newswire)
May-15-24 02:13AM	Q1 2024 Smart Sand Inc Earnings Call (Thomson Reuters StreetEvents)
May-13-24 09:54PM	SND Stock Earnings: Smart Sand Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:45PM	Smart Sand (SND) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:41PM	Smart Sand: Q1 Earnings Snapshot (Associated Press Finance)
04:31PM	Smart Sand, Inc. Announces First Quarter 2024 Results (PR Newswire)
May-02-24 09:41AM	SMART SAND, INC. ANNOUNCES TIMING OF FIRST QUARTER 2024 EARNINGS RELEASE AND INVESTOR CONFERENCE CALL (PR Newswire)
09:40AM	Should Value Investors Buy Smart Sand (SND) Stock? (Zacks)
Apr-15-24 09:40AM	Are Investors Undervaluing Smart Sand (SND) Right Now? (Zacks)
Mar-28-24 09:40AM	Should Value Investors Buy Smart Sand (SND) Stock? (Zacks)
Mar-13-24 08:11AM	Smart Sand, Inc. (NASDAQ:SND) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-12-24 11:46PM	Q4 2023 Smart Sand Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-11-24 06:10PM	Smart Sand (SND) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:19PM	Smart Sand: Q4 Earnings Snapshot (Associated Press Finance)
05:00PM	Smart Sand, Inc. Announces Fourth Quarter 2023 and Full Year 2023 Results (PR Newswire)
Feb-28-24 06:02AM	Smart Sand, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Investor Conference Call (GlobeNewswire)
Jan-01-24 04:00PM	3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition (InvestorPlace)
Nov-09-23 02:34PM	Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript (Insider Monkey)
03:56AM	Q3 2023 Smart Sand Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-07-23 05:52PM	Smart Sand: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Smart Sand, Inc. Announces Third Quarter 2023 Results (GlobeNewswire)
09:15AM	Global Energy Storage System Market Expected To Reach A Revenue Of $80 Billion in 2035 (PR Newswire)
Oct-20-23 04:03PM	Smart Sand, Inc. Announces Timing of Third Quarter Earnings Release and Investor Conference Call (GlobeNewswire)
Aug-13-23 11:38AM	12 Best Quality Penny Stocks to Buy (Insider Monkey)
Aug-10-23 06:37AM	The Returns On Capital At Smart Sand (NASDAQ:SND) Don't Inspire Confidence (Simply Wall St.)
Aug-09-23 11:53PM	Q2 2023 Smart Sand Inc Earnings Call (Thomson Reuters StreetEvents) +7.87%
Aug-08-23 04:54PM	Smart Sand: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Smart Sand, Inc. Announces Second Quarter 2023 Results (GlobeNewswire)
01:24PM	28th Annual EnerCom Denver - The Energy Investment Conference Set to be held August 13-16, 2023 in Denver, Colorado (PR Newswire)
Jul-29-23 06:53AM	10 Best Oil and Gas Penny Stocks to Buy (Insider Monkey)
Jul-27-23 02:16PM	Energy Transition and Emerging Technology Companies are Set to Present at the 28th Annual EnerCom Denver - The Energy Investment Conference, to be held August 13-16, 2023, in Denver, Colorado (PR Newswire)
Jul-25-23 04:26PM	Smart Sand, Inc. Announces Timing of Second Quarter Earnings Release and Investor Conference Call (GlobeNewswire)
Jul-20-23 05:11PM	Presentation Times and Schedule for Participating Companies Now Posted on the Conference Website for 28th Annual EnerCom Denver - The Energy Investment Conference, to be held August 13-16, 2023, in Denver, Colorado (PR Newswire)
Jul-19-23 11:37AM	Halliburton (HAL) Q2 Earnings Beat as Both Units Outperform (Zacks)
Jul-13-23 01:00PM	Investor One-on-One Meeting Requests Open for 28th Annual EnerCom Denver - The Energy Investment Conference, to be held August 13-16, 2023 in Denver, Colorado (PR Newswire)
Jul-12-23 08:56AM	Ring Energy (REI) to Acquire Permian Basin Assets for $75M (Zacks)
Jul-10-23 08:00AM	Expro's (XPRO) Unique Subsea Technology Gets 3-Year Contract (Zacks)
07:54AM	What Did Shell (SHEL) Reveal in Its Update Pre Q2 Earnings? (Zacks)
Jun-29-23 08:43AM	Transocean (RIG) Announces $184 Million Addition to Backlog (Zacks)
Jun-27-23 09:20AM	Vertex (VTNR) Reports First Renewable Diesel Transaction (Zacks)
Jun-23-23 09:12AM	KLX Energy (KLXE) Amends Credit Facility, Gets More Funds (Zacks)
Jun-21-23 08:11AM	TechnipFMC (FTI) Surges 118% in a Year: Is it Sustainable? (Zacks)
Jun-20-23 07:00AM	Proppant Choice at the Oil Well Drives Efficient Operations: In-Basin Sand is Cheaper Upfront, but Quickly Erodes Cash Flow and Profitability (GlobeNewswire)
Jun-15-23 06:30AM	Unparalleled Networking Opportunities at 28th Annual EnerCom Denver - The Energy Investment Conference, to be held August 13-16, 2023 in Denver, Colorado Include Charity Golf Tournament and Hole-in-One Contest, Monday Mixer Cocktail Reception and Colorado Rockies Baseball Game (PR Newswire) +5.73%
Jun-01-23 01:37PM	EnerCom Announces Liberty Energy and Strive Asset Management as Keynote Speakers at EnerCom Denver - The Energy Investment Conference, to be held August 13-16, 2023, in Denver, Colorado (PR Newswire)
May-13-23 03:12PM	Smart Sand, Inc. (NASDAQ:SND) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-10-23 10:53PM	Q1 2023 Smart Sand Inc Earnings Call (Thomson Reuters StreetEvents) -11.05%
09:40AM	Is SolarEdge Technologies (SEDG) Outperforming Other Oils-Energy Stocks This Year? (Zacks)
May-09-23 05:14PM	Smart Sand: Q1 Earnings Snapshot (AP Finance)
04:05PM	Smart Sand, Inc. Announces First Quarter 2023 Results (GlobeNewswire)
09:40AM	Are Investors Undervaluing NexTier Oilfield Solutions (NEX) Right Now? (Zacks)
07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
May-03-23 06:00PM	Smart Sand (SND) Dips More Than Broader Markets: What You Should Know (Zacks)
May-02-23 03:30PM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
Apr-27-23 06:00PM	Smart Sand (SND) Flat As Market Gains: What You Should Know (Zacks) +7.50%
Apr-21-23 09:40AM	Are Investors Undervaluing Smart Sand (SND) Right Now? (Zacks)
Apr-19-23 06:00PM	Smart Sand (SND) Gains As Market Dips: What You Should Know (Zacks)
04:05PM	Smart Sand, Inc. Announces Timing of First Quarter Earnings Release and Investor Conference Call (GlobeNewswire)
06:51AM	Smart Sand's (NASDAQ:SND) investors will be pleased with their stellar 149% return over the last three years (Simply Wall St.)
Apr-17-23 06:15PM	Smart Sand (SND) Outpaces Stock Market Gains: What You Should Know (Zacks)
Apr-10-23 06:15PM	Smart Sand (SND) Outpaces Stock Market Gains: What You Should Know (Zacks)
Apr-04-23 09:40AM	Should Value Investors Buy Smart Sand (SND) Stock? (Zacks)

Smart Sand, Inc. engages in supplying frac sand and related services. The firm offers complete mine to wellsite proppant supply and logistics solutions. It operates through the Sand and SmartSystems segments. The Sand segment includes both frac sand sales and IPS sales. The SmartSystems segment focuses on the rental of patented SmartSystems equipment and related services provided to customers. The company was founded by Charles E. Young on July 19, 2011 and is headquartered in Yardley, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WHELAN RONALD P	SEE REMARKS	Nov 28 '25	Buy	2.91	4,325	12,586	457,266	Dec 01 07:56 AM
WHELAN RONALD P	SEE REMARKS	Nov 26 '25	Buy	2.94	3,333	9,799	452,941	Dec 01 07:56 AM
YOUNG CHARLES EDWIN	CEO	Sep 05 '25	Buy	1.91	20,000	38,200	1,477,628	Sep 05 04:37 PM
YOUNG CHARLES EDWIN	CEO	Sep 03 '25	Buy	1.89	10,630	20,091	1,449,227	Sep 05 04:37 PM
YOUNG CHARLES EDWIN	CEO	Sep 04 '25	Buy	1.92	8,401	16,130	1,457,628	Sep 05 04:37 PM
Green Christopher M.	Vice President of Accounting	Aug 28 '25	Sale	1.95	11,500	22,425	53,959	Sep 02 04:01 PM
YOUNG CHARLES EDWIN	CEO	Aug 15 '25	Buy	1.92	29,592	56,817	1,418,189	Aug 19 04:08 PM
YOUNG CHARLES EDWIN	CEO	Aug 18 '25	Buy	1.87	11,498	21,501	1,429,687	Aug 19 04:08 PM
YOUNG CHARLES EDWIN	CEO	Aug 19 '25	Buy	1.96	8,910	17,464	1,438,597	Aug 19 04:08 PM

Open in Screener

CZFS

Citizens Financial Services, Inc

Dec 01 • 11:07AM ET

56.50

+0.61 1.09 %

Financial • Banks - Regional • USA • NASD

CZFS Citizens Financial Services, Inc daily Stock Chart

Peers: HBAN RF FNB UBSI FULT WAL OZK TMP WSBC NBHC

| Held by: VTI IWM VXF IWN SCHA VTWO AVUV IWC SMLV AVSC

Index	RUT	P/E	7.96	EPS (ttm)	7.10	Insider Own	6.23%	Shs Outstand	4.81M	Perf Week	-1.22%
Market Cap	271.56M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.83%	Shs Float	4.51M	Perf Month	4.15%
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	27.19%	Short Float	0.78%	Perf Quarter	-5.58%
Income	34.07M	P/S	1.58	EPS this Y	-	Inst Trans	0.36%	Short Ratio	4.04	Perf Half Y	-6.33%
Sales	171.93M	P/B	0.83	EPS next Y	-	ROA	1.12%	Short Interest	0.03M	Perf YTD	-10.76%
Book/sh	68.18	P/C	-	EPS next 5Y	-	ROE	10.88%	52W High	73.59 -23.22%	Perf Year	-20.33%
Cash/sh	-	P/FCF	10.79	EPS past 3/5Y	-6.53% 2.13%	ROIC	5.61%	52W Low	49.99 13.02%	Perf 3Y	-18.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	25.83% 19.35%	Gross Margin	-	Volatility	3.13% 3.27%	Perf 5Y	16.34%
Dividend TTM	1.97 (3.50%)	EV/Sales	-	EPS Y/Y TTM	24.43%	Oper. Margin	24.25%	ATR (14)	1.83	Perf 10Y	105.71%
Dividend Ex-Date	Sep 12, 2025	Quick Ratio	-	Sales Y/Y TTM	2.16%	Profit Margin	19.82%	RSI (14)	51.32	Recom	1.00
Dividend Gr. 3/5Y	2.54% 2.81%	Current Ratio	0.03	EPS Q/Q	32.78%	SMA20	0.79%	Beta	0.47	Target Price	65.00
Payout	33.34%	Debt/Eq	0.85	Sales Q/Q	4.11%	SMA50	-0.27%	Rel Volume	0.27	Prev Close	55.89
Employees	410	LT Debt/Eq	0.85	Earnings	Oct 30 BMO	SMA200	-3.06%	Avg Volume	8.66K	Price	56.50
IPO	Apr 05, 1994	Option/Short	No / Yes	EPS/Sales Surpr.	18.75% -	Trades		Volume	680	Change	1.09%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-30-24	Upgrade	Janney	Neutral → Buy	$53
Jun-29-23	Downgrade	Janney	Buy → Neutral

Oct-30-25 10:05AM	Citizens Financial Services (CZFS) Q3 Earnings Top Estimates (Zacks)
08:58AM	Citizens Financial Services: Q3 Earnings Snapshot (Associated Press Finance)
08:50AM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED THIRD QUARTER 2025 FINANCIAL RESULTS (PR Newswire)
Oct-21-25 06:20PM	Pathward Financial (CASH) Q4 Earnings Beat Estimates (Zacks)
Oct-15-25 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
11:45AM	Loading…
Sep-29-25 11:45AM	Why Citizens Financial Services (CZFS) is a Great Dividend Stock Right Now (Zacks)
Sep-24-25 05:43AM	Best Income Stocks to Buy for September 24th (Zacks)
Sep-12-25 11:45AM	Citizens Financial Services (CZFS) Could Be a Great Choice (Zacks)
Sep-10-25 05:56AM	New Strong Buy Stocks for September 10th (Zacks)
05:15AM	Best Value Stocks to Buy for September 10th (Zacks)
04:10AM	Best Income Stocks to Buy for September 10th (Zacks)
Sep-09-25 09:10AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
Sep-08-25 05:37AM	New Strong Buy Stocks for September 8th (Zacks)
03:17AM	Best Income Stocks to Buy for September 8th (Zacks)
Aug-27-25 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
12:00PM	Loading…
Aug-22-25 12:00PM	Citizens Financial Services (CZFS) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks) +5.89%
Aug-19-25 08:52AM	Best Value Stocks to Buy for August 19th (Zacks)
Aug-11-25 11:45AM	Why Citizens Financial Services (CZFS) is a Great Dividend Stock Right Now (Zacks)
06:18AM	Best Value Stocks to Buy for August 11th (Zacks)
03:30AM	Best Income Stocks to Buy for August 11th (Zacks)
Aug-05-25 08:44AM	Best Value Stocks to Buy for August 5th (Zacks)
08:01AM	Best Income Stocks to Buy for August 5th (Zacks)
Jul-30-25 06:35PM	Citizens Financial Services (CZFS) Q2 Earnings and Revenues Surpass Estimates (Zacks)
05:37PM	Citizens Financial Services: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED SECOND QUARTER 2025 FINANCIAL RESULTS (PR Newswire)
Jul-28-25 05:55PM	LINKBANCORP, Inc. (LNKB) Matches Q2 Earnings Estimates (Zacks) -5.02%
Jul-25-25 11:45AM	Why Citizens Financial Services (CZFS) is a Top Dividend Stock for Your Portfolio (Zacks)
Jul-24-25 05:45PM	Byline Bancorp (BY) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-09-25 11:45AM	Citizens Financial Services (CZFS) Could Be a Great Choice (Zacks)
Jun-23-25 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
09:10AM	Loading…
Jun-10-25 09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
Jun-06-25 11:45AM	Citizens Financial Services (CZFS) Could Be a Great Choice (Zacks)
May-21-25 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
May-05-25 11:45AM	Why Citizens Financial Services (CZFS) is a Great Dividend Stock Right Now (Zacks)
Apr-30-25 09:50AM	Citizens Financial Services (CZFS) Beats Q1 Earnings Estimates (Zacks)
08:40AM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED FIRST QUARTER 2025 FINANCIAL RESULTS (PR Newswire)
Apr-18-25 11:45AM	Why Citizens Financial Services (CZFS) is a Top Dividend Stock for Your Portfolio (Zacks)
Apr-10-25 08:14AM	Webster Financial (WBS) Moves 11.6% Higher: Will This Strength Last? (Zacks)
Apr-02-25 11:45AM	Citizens Financial Services (CZFS) is a Top Dividend Stock Right Now: Should You Buy? (Zacks)
Mar-22-25 12:31AM	Dividend Champion, Contender, And Challenger Highlights: Week Of March 23 (SeekingAlpha)
Jan-30-25 04:25PM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED FULL YEAR AND FOURTH QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Oct-30-24 04:15PM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED THIRD QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Jul-30-24 10:52PM	CZFS Stock Earnings: Citizens Financial Servs Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace)
04:15PM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED SECOND QUARTER 2024 FINANCIAL RESULT (PR Newswire)
Apr-25-24 09:54PM	CZFS Stock Earnings: Citizens Financial Servs Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -5.15%
04:15PM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED FIRST QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Jan-30-24 06:38PM	/C O R R E C T I O N -- CITIZENS FINANCIAL SERVICES, INC./ (PR Newswire)
04:15PM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED FULL YEAR AND FOURTH QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Oct-23-23 10:07AM	Citizens Financial Services Q3 EPS Declines (RTT News)
09:32AM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED THIRD QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Oct-06-23 12:00PM	Citizens Financial Services (CZFS) Upgraded to Strong Buy: Here's Why (Zacks)
Jul-31-23 04:10PM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED SECOND QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Jun-16-23 04:32PM	Citizens Financial Services, Inc. Announces Completion of Merger with HV Bancorp, Inc. (PR Newswire)
Jun-13-23 09:22AM	Citizens Financial Services, Inc. Announces Preliminary Results of Merger Consideration Elections Regarding Pending HV Bancorp, Inc. Merger (PR Newswire) -6.76%
Jun-09-23 09:00AM	Exchange Ratio Finalized for Citizens Financial Services, Inc. Pending HV Bancorp, Inc. Merger (PR Newswire)
May-09-23 09:00AM	Citizens Financial Services, Inc. and HV Bancorp, Inc. Announce Election Deadline (PR Newswire)
Apr-27-23 06:34PM	CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED FIRST QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Apr-10-23 04:05PM	Citizens Financial Services, Inc. Announces Receipt of Regulatory Approvals for the Acquisition of HV Bancorp, Inc. (PR Newswire)

Citizens Financial Services, Inc. is a holding company, which operates as a community bank. The company was founded in 1984 and is headquartered in Mansfield, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Guillaume Stephen J	SENIOR VICE PRESIDENT	Nov 28 '25	Buy	53.10	16	850	4,570	Dec 01 09:54 AM
BLACK RANDALL E	CEO & PRESIDENT	Nov 04 '25	Buy	54.25	22	1,194	44,035	Nov 05 10:50 AM
BLACK RANDALL E	CEO & PRESIDENT	Nov 03 '25	Buy	54.10	478	25,862	44,013	Nov 04 07:31 AM
Guillaume Stephen J	SENIOR VICE PRESIDENT	Aug 31 '25	Buy	56.96	13	740	4,524	Sep 02 11:51 AM
Freeman Thomas E.	Director	Aug 22 '25	Sale	60.00	3,000	180,000	12,569	Aug 22 02:33 PM
Gephart LeeAnn	EXECUTIVE VICE PRESIDENT	Jul 08 '25	Sale	59.64	14	835	720	Jul 08 02:45 PM
Gephart LeeAnn	EXECUTIVE VICE PRESIDENT	Jun 24 '25	Sale	59.58	33	1,966	728	Jun 26 09:12 AM
Guillaume Stephen J	EXECUTIVE VICE PRESIDENT	May 30 '25	Buy	58.09	15	871	4,452	Jun 02 07:24 AM
Painter John P II	Director	May 06 '25	Buy	57.40	215	12,341	2,402	May 06 03:50 PM
Guillaume Stephen J	EXECUTIVE VICE PRESIDENT	Feb 28 '25	Buy	57.45	13	747	4,077	Mar 03 09:52 AM
Painter John P II	Director	Feb 03 '25	Buy	60.00	110	6,600	2,088	Feb 04 01:55 PM

Black Swan Sale

50% Off Elite

ALIT

NRDY

OBDC

DGICA

KTTA

MAIA

SUNC

SND

CZFS

Upgrade your FINVIZ experience